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ABSTRACT
Vibrio vulnificus, a Gram-negative halophile which is ubiquitously present in the marine
environments, can cause diseases like gastroenteritis, septicemia and wound infections in
susceptible human beings. Production of capsular polysaccharide results in an opaque phenotype,
which is pathogenic to humans. Loss or reduction of capsule results in translucent colonies
composed of cells that are nonpathogenic or have diminished virulence, respectively. The opaque
and the translucent phenotypes, upon production of an exopolysaccharide, give rise to a dry,
wrinkled rugose form that can form copious biofilms. These three phenotypes can spontaneously
switch from one form to another in a process known as phase variation. In this study, we have
sought to identify environmental factors and genetic mechanisms that affect phase variation and
biofilm formation in V. vulnificus. Elements such as Ba2+, Mn2+, and Sr2+, were tested to determine
their effect on V. vulnificus phase variation and we found that manganese at micromolar to
millimolar concentrations, induces V.vulnificus polysaccharide phase variation from opaque to
translucent or rugose forms in this species. Since calcium was previously shown to induce
significant phase variation in different V.vulnificus strains, we have also attempted to compare the
effects of equimolar addition of manganese and calcium on phase variation of different
V.vulnificus strains. Here, we have also attempted to better understand the process of V. vulnificus
rugose colony formation. Our study has identified 28 proteins that include translational elongation
factors, various metabolic enzymes, proteases, sugar binding proteins, amino acid transporters,
polar flagellins and an uncharacterized protein that are differentially expressed in the biofilm
proficient rugose phase variant compared to the parent isogenic opaque phase variant. One protein
of particular interest, MalE (VVA0397 gene product), a maltose binding periplasmic protein, was
ix

identified as being expressed at higher amounts, and concomitantly showed higher transcript levels
in the rugose variant compared to the opaque variant. Interestingly, generation of a targeted mutant
of the malE gene did not knock out rugosity, indicating that the malE (VVA0397) gene is not
required for rugosity in V.vulnificus. However, its up-regulation at both the transcriptional and
translational levels suggests that MalE protein is involved in rugose colony formation in a way
that remains to be determined.

x

CHAPTER 1
INTRODUCTION
It was in 1883 that Koch first cultured V. cholerae from epidemics in India and Egypt
(Thompson, Iida et al. 2004). It was then that intensive studies were undertaken to identify and
differentiate pathogenic vibrios from the nonpathogenic ones (Farmer and Hickman-Brenner
2006). Then in the late 1940’s, Fujino isolated V. parahaemolyticus from a food poisoning
outbreak in Oaska, Japan (Fujino, Resources et al. 1974). Later on in 1976, Hollis et al., reported
the isolation of a bacterium from blood samples that was similar to V. parahaemolyticus, but
differed from other vibrios, and was able to ferment lactose, and required salt for its growth (Hollis,
Weaver et al. 1976). This bacterium was called Beneckea vulnifica by Reichelt et al. (Reichelt,
Baumann et al. 1976), but as this nomenclature was not widely accepted, it was finally renamed
Vibrio vulnificus by Farmer et al. (Farmer 1979).
Vibrio vulnificus is a Gram-negative, motile, curved bacillus, naturally occurring in coastal,
estuarine and marine environments around the world (Tamplin, Rodrick et al. 1982, Myatt and
Davis 1989, Maxwell, Mayall et al. 1991, O'Neill, Jones et al. 1992, Veenstra, Rietra et al. 1994,
Dalsgaard, Frimodt-Moller et al. 1996, Wright, Hill et al. 1996, Hoi, Larsen et al. 1998, Shapiro,
Altekruse et al. 1998). In these environments, V. vulnificus exists freely in the water columns and
sediments, also attaches to plankton and moreover is concentrated in seafood such as the guts of
filter feeding mollusks including shrimp, lobsters and oysters (Elmore, Watts et al. 1992, DePaola,
Capers et al. 1994, do Nascimento, dos Fernandes Vieira et al. 2001, Baffone, Tarsi et al. 2006,
Mahmud, Neogi et al. 2008). V. vulnificus is a halophile which can survive in salinities ranging
from 15 to 25 parts per thousand (Motes, DePaola et al. 1998) and temperatures ranging from 10
to 31 °C. When the water temperature drops below 10 °C, it enters the viable but non-culturable
1

(VBNC) state in which the bacteria are alive but cannot be immediately cultured (Oliver, Warner
et al. 1982, Kaysner, Abeyta et al. 1987, Oliver, Hite et al. 1995). Resuscitation from the VBNC
state occurs in warmer temperatures within 7-10 days (Oliver and Bockian 1995).
Six strains of V. vulnificus have been sequenced (Gulig, de Crecy-Lagard et al. 2010) and
sequencing

of

additional

genomes

is

underway

(http://www.ncbi.nlm.nih.gov/genome/genomes/189). The total genome size so far ranges from
4.33 to 5.75 Mb. The genome of V. vulnificus is made up of two circular chromosomes, a larger
one ranging from 3.19 to 3.35 Mb and a smaller one ranging from 1.81 to 1.85 Mb. The GC % in
different strains ranges from 44.9 to 47. The number of genes range from 4,572 to 5,166 and the
number of proteins range from 4,433 to 5,023 (Chen, Wu et al. 2003, Kim, Lee et al. 2003, Park,
Cho et al. 2011) (http://www.ncbi.nlm.nih.gov/genome/genomes/189).
Vibrio vulnificus has the highest fatality rate of any seafood pathogen and deaths occur in
50 % of the cases after the onset of disease (Oliver 2013). As reviewed previously by Jones and
Oliver (Jones and Oliver 2009), infections are more common in the warmer months of May through
October. The concentration of V. vulnificus in raw oysters can reach as high as 1 x 103 to 1 x 106
bacteria per gram of oyster meat in the warm summer months in the Gulf of Mexico (Tamplin,
Rodrick et al. 1982, Wright, Hill et al. 1996, Motes, DePaola et al. 1998). Males are more
susceptible to infection compared to females due to the protective action of estrogen against
endotoxic shock (Merkel, Alexander et al. 2001). Consumption of raw oysters by people with
preexisting medical conditions, such as hemochromatosis, which is an iron imbalance in the body,
diabetes, liver cirrhosis, alcoholism, kidney problems and immunocompromised systems, renders
them more at risk to develop serious septicemic infections (Bullen, Spalding et al. 1991, Kraffert
2

and Hogan 1992, Hlady and Klontz 1996, Kumamoto and Vukich 1998, Gulig, Bourdage et al.
2005), which are characterized by fever, chills and hypotensive septic shock (Chuang, Yuan et al.
1992, Hlady and Klontz 1996, Klontz, Lieb et al. 1988, Strom and Paranjpye 2000). Also exposure
of skin abrasions to contaminated seafood drippings or seawater can result in wound infections
that may require tissue debridement, skin grafts or even limb amputation in very severe cases
(Hollis, Weaver et al. 1976, Gulig, Bourdage et al. 2005). Even with treatment, mortality in case
of septicemia can be 75 % and that in case of wound infections can be as high as 50 % (Hlady and
Klontz 1996).
As reviewed by Jones and Oliver (Jones and Oliver 2009), the US Food drug and
administration (FDA) has reported an average of 34 cases of infection annually caused by V.
vulnificus. Also, data from the Centers for Disease Control and Prevention (CDC) has indicated
that the number of V. vulnificus cases is progressively increasing over the years. Between 1996
and 2006 there was a 76 % increase in V. vulnificus cases. This increase in the number of V.
vulnificus infections may be related to global warming leading to higher water temperatures (Paz,
Bisharat et al. 2007). Wound infections in particular have been on the rise in the US (Craig, Joaquin
et al. 2012). Even though the number of V. vulnificus cases recorded are on an increase, and the
actual number of deaths caused by V. vulnificus are low, the opportunistic nature of this bacterium
poses a risk to nearly 12-30 million American people who have at least one of the several
predisposing conditions mentioned previously (Jones and Oliver 2009). This disparity in the
number of infections caused by V.vulnificus and the number of susceptible individuals, hints
towards the fact that the majority of the strains in the environment are not pathogenic (Oliver
2012). It was shown under laboratory conditions, that V. vulnificus environmental (E) genotype
3

strains are better at forming marine aggregates, which are better taken up by oysters compared to
clinical (C) genotype strains (Froelich, Ayrapetyan et al. 2013).
Several virulence factors, such as capsule (Amako, Okada et al. 1984, Yoshida, Ogawa et
al. 1985, Simpson, White et al. 1987, Wright, Simpson et al. 1990), iron acquisition systems
(Wright, Simpson et al. 1981, Simpson and Oliver 1983), flagella (Ran Kim and Haeng Rhee 2003,
Lee, Rho et al. 2004, Natividad-Bonifacio, Fernandez et al. 2013, Kim, Thanh et al. 2014), pili
(Paranjpye, Lara et al. 1998, Paranjpye and Strom 2005, Horseman and Surani 2011, NatividadBonifacio, Fernandez et al. 2013), hemolysins - cytolysins (Johnson and Calia 1981, Kreger and
Lockwood 1981, Gray and Kreger 1985, Yamamoto, Wright et al. 1990, Wright and Morris 1991,
Kook, Lee et al. 1996, Natividad-Bonifacio, Fernandez et al. 2013), metalloproteases (Miyoshi,
Hirata et al. 1994, Chuang, Sheu et al. 1997, Chang, Kim et al. 2005, Shinoda 2005, Shinoda and
Miyoshi 2011, Miyoshi 2013), RtxA toxin (Lee, Kim et al. 2007, Lee, Choi et al. 2008, Lee, Lee
et al. 2008, Kwak, Jeong et al. 2011, Lo, Lin et al. 2011, Kim, Lee et al. 2013, Natividad-Bonifacio,
Fernandez et al. 2013) and lipopolysaccharide (LPS) (McPherson, Watts et al. 1991), have been
reported; however, of all these, the capsule is considered to be the major virulence factor (Jones
and Oliver 2009).
Numerous studies have been devoted to identifying the differences between environmental
and clinical V. vulnificus isolates. V. vulnificus has been classified based on biotypes, antigens,
capsule composition, LPS composition and genetic sequences (Gulig, Bourdage et al. 2005).
Biochemically, V. vulnificus has been divided into 3 biotypes (Bisharat, Agmon et al. 1999).
Biotype 1 strains are human pathogens, and are indole and ornithine decarboxylase positive.
Biotype 2 strains are eel pathogens and are indole and ornithine decarboxylase negative. Biotype
4

3 strains are human pathogens isolated as yet only from Israel, and are indole and ornithine
decarboxylase positive. Biotype 1 strains are heterogeneous in their LPS composition based on
their reaction to LPS monoclonal antibodies (Martin and Siebeling 1991). In contrast, biotype 2
strains possess only one type of LPS (Biosca, Oliver et al. 1996). Since the capsule is considered
to be the major virulence marker in V. vulnificus infections, a number of studies have been
performed to distinguish the clinical and environmental strains based on their capsule type.
Carbohydrate analysis of clinical and environmental strains revealed that capsular carbohydrate
composition was very heterogeneous among the strains studied (Hayat, Reddy et al. 1993, Bush,
Patel et al. 1997). Based on the results from the LPS and capsular polysaccharide (CPS)
composition analysis, any correlation with the CPS or LPS type and less virulent (e.g.
environmental) vs. more virulent (e.g. clinical) strains could not be established.
A number of genotyping approaches have also been undertaken to distinguish virulent
versus non-virulent V. vulnificus strains. Randomly amplified polymorphic DNA – polymerase
chain reaction (RAPD-PCR) identified the presence of a virulence correlated gene (vcg) in human
clinical isolates but it was generally absent from environmental strains isolated from water (Warner
and Oliver 1998). Further studies comparing the ‘vcg’ gene sequence from clinical and
environmental strains identified allelic differences between the sequences. Alleles specific to the
clinical and the environmental strains were termed as vcgC and vcgE, respectively (Rosche, Yano
et al. 2005). Differences in restriction fragment length polymorphism (RFLP) of the 16S rRNA
genetic sequences have also been used to distinguish between clinical and environmental isolates.
In this case, environmental isolates were designated ‘A’ type and clinical isolates were designated
as ‘B’ type (Nilsson, Paranjype et al. 2003). Later, PCR and sequence analysis of the intergenic
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spacer region (ISR1) between the 16S rRNA and the 23S rRNA genes demonstrated that two
groups of strains exist: one containing clinical, 16 S rRNA RFLP profile B strains, while the other
group contained only the environmental 16 S rRNA A-type strains (Gonzalez-Escalona, Jaykus et
al. 2007). Multilocus sequence typing (MLST) of 6 housekeeping genes divided V. vulnificus
strains into two lineages: lineage I, which contained biotype 1 strains, and lineage II, which
contained biotype 1 and 2 strains; however, the proportion of clinical isolates was higher in lineage
I than in lineage II (Cohen, Oliver et al. 2007). Furthermore, it was also shown that 16S rRNA
RFLP profile A strains, have allele 2 of the type I CPS operon while 16S RFLP profile B strains
have allele 1 (Chatzidaki-Livanis, Hubbard et al. 2006, Chatzidaki-Livanis, Jones et al. 2006,
Cohen, Oliver et al. 2007).
Subsequently, genomes of four V. vulnificus strains were compared by SOLiD sequencing,
which grouped 2 clinical strains in Clade 2 and two environmental isolates in Clade 1. This study
detailed a number of genes unique to the each of the clades and also revealed that Clade 2 possessed
more virulence potential than Clade 1. (Gulig, de Crecy-Lagard et al. 2010). Pyrosequencing of 3
environmental V. vulnificus strains and their comparison to genomes of 3 sequenced clinical V.
vulnificus strains have identified 167 genes to be exclusively associated with E genotype and 278
genes associated with the C genotype (Morrison, Williams et al. 2012). Strains with the E
phenotype had a significant enrichment of genes functioning in urea, nitrogen metabolism and
proteins involved in chitin hydrolysis, while strains with the C genotype had genes involved in
sialic acid (neuraminic acid derivatives) metabolism, type IV secretory pathway and unique cyclic
di GMP proteins (Morrison, Williams et al. 2012). However, none of the aforementioned studies
consistently demonstrate genetic differences between virulent and non-virulent strains.
6

Production of the major virulence factor, CPS, by V. vulnificus, results in opaque colonies
on agar surfaces that appear smooth, shiny and mucoid (Amako, Okada et al. 1984, Yoshida,
Ogawa et al. 1985, Simpson, White et al. 1987). Cells in these opaque colonies are able to kill an
iron loaded mouse at an LD50 (lethal dose required to kill 50 % of the test population) value of as
low as one cell (Zuppardo and Siebeling 1998). Loss or reduction of capsular material results in
translucent colonies (Yoshida, Ogawa et al. 1985, Simpson, White et al. 1987, Wright, Simpson
et al. 1990), or colonies with an intermediate phenotype (Chatzidaki-Livanis, 2006, Rosche, 2006).
Cells in translucent or intermediate colonies are attenuated for virulence as pathogenicity
correlates to the amount of capsule production (Amako, 1984, Yoshida, 1985, Wright, 1990,
Zuppardo, 1998, Wright, 2001, Grau, 2005). A number of studies have reported that some
translucent V. vulnificus strains are not virulent enough to kill an iron overloaded mouse, even at
relatively high CFU’s (Amako, Okada et al. 1984, Yoshida, Ogawa et al. 1985, Wright, Simpson
et al. 1990, Zuppardo and Siebeling 1998, Wright, Powell et al. 2001, Grau, Henk et al. 2005).
Both the opaque and the translucent phenotypes, upon production of a separate exopolysaccharide
(EPS), give rise to rugose colonies, which appear dry and wrinkled on agar surfaces. Rugose cells
can form profuse biofilms (Grau, Henk et al. 2005), and may be pathogenic only if derived from
an encapsulated parent (Grau, Henk et al. 2008). The opaque, translucent and rugose phenotypes
possess the capability to spontaneously switch from one phenotype to the other by the loss or gain
of expression of surface polysaccharides, and this process is referred to as phase variation (Grau,
Henk et al. 2005). Phase variation is defined as the reversible change in phenotype caused by
genetic or epigenetic changes that aid in the survival or adaptation of different organisms (van der
Woude and Baumler 2004, Wisniewski-Dyé and Vial 2008). While spontaneous mutations in
7

bacteria have been reported to occur at the rate of 1 in 108 cells per generation, phase variation
occurs at a much higher frequency of 1 in 103 cells per generation or greater (Salaun, Snyder et al.
2003, van der Woude and Baumler 2004).
Several studies have elucidated environmental and genetic causes that form the basis of
phase variation. Surface structures such as proteins, pili, fimbriae, flagella, LPS, capsule and
exopolysaccharides have been shown to undergo phase variation in different organisms (van der
Woude and Baumler 2004). A number of environmental influences triggering phase variation have
been documented as well. For example, pili in Neisseria gonorrhoeae undergo increased frequency
of phase variation due to iron starvation (Serkin and Seifert 2000). Temperature, pH, carbon source
and amino acid concentration affect fimbrial phase variation in Escherichia coli and Salmonella
typhimurium (van der Woude and Baumler 2004). Also, various genetic mechanisms such as site
specific recombination, homologous recombination, insertions, deletions and slipped strand
mispairing as well as epigenetic mechanisms such as methylation have been identified to be the
underlying basis of phase variation in different organisms (van der Woude and Baumler 2004,
Wisniewski-Dyé and Vial 2008).
Since the presence of capsule in V.vulnificus, directly correlates with the ability to cause
human diseases, a lot of work has been focused on identifying the genes involved in capsule
biosynthesis and, importantly, the factors that bring about a switch from the opaque virulent to the
translucent avirulent phenotype. The capsule provides resistance to opsonization by complement
and therefore prevents phagocytosis by macrophages (Tamplin, Specter et al. 1983, Tamplin,
Specter et al. 1985, Yoshida, Ogawa et al. 1985, Kashimoto, Ueno et al. 2003). In addition, the
capsule aids in immune evasion by masking immunogenic moieties that would activate the
8

nonspecific responses in the host (Yoshida, Ogawa et al. 1985, Roberts 1996, Kashimoto, Ueno et
al. 2003). The presence of the capsule slows the clearing of this bacterium from the blood stream,
and also causes the strains to be more invasive in subcutaneous tissue infections (Yoshida, Ogawa
et al. 1985). Several genes have been shown to be responsible for capsule production in V.
vulnificus, and mutations in these genes have eliminated capsule production and caused the
resultant mutants to appear translucent. Examples include epimerase genes such as wcvA and wbpP
(Zuppardo and Siebeling 1998, Smith and Siebeling 2003, Park, Lee et al. 2006),
glycosyltransferase genes, such as

wcvF and wcvI (Smith and Siebeling 2003), and a

polysaccharide polymerase gene, such as wzy (Nakhamchik, Wilde et al. 2007). A group I CPS
operon composed of the highly conserved wza-wzb-wzc genes, an operon polarity suppressor (ops)
element, and other less-conserved capsule biosynthesis genes were also identified as being
involved in capsule production (Wright, Powell et al. 2001). Mutations in wza, which is a
polysaccharide transporter, resulted in colonies that could not produce capsule and remained phase
locked in the translucent state (Wright, Powell et al. 2001, Chatzidaki-Livanis, Jones et al. 2006).
It was also demonstrated that deletion of the wzb gene (a tyrosine phosphatase required in capsular
polysaccharide chain elongation), caused by homologous recombination between flanking direct
repeats also resulted in phase locked translucent colonies (Chatzidaki-Livanis, Jones et al. 2006).
Reverse transcriptase PCR data has shown that reduced transcription of the wzb gene was
associated with colonies of an intermediate phenotype (Rosche, Smith et al. 2006). In 2011, our
lab demonstrated that the opaque to translucent phase switch of V. vulnificus growing in LB2
supplemented with 1 mM Ca2+, sometimes corresponded with deletions in the wzb gene (GarrisonSchilling, Grau et al. 2011).
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A number of regulators have also been demonstrated to be involved in the process of V.
vulnificus phase variation. Deletions in rseB, a periplasmic negative regulator of alternative sigma
factor E (involved in heat stress response) have been associated with reversible phase variation in
V. vulnificus (Brown and Gulig 2009). It has been reported in V. vulnificus that phase variation is
influenced by rpoS, which is a sigma factor involved in bacterial stress response (Hilton, Rosche
et al. 2006, Gauthier, Jones et al. 2010). Deletions in gacA, which is a response regulator involved
in a two-component signal transduction system, significantly decreased phase variation of the
opaque to the translucent phenotype, which the authors speculated was due to reduction of rpoS
mRNA in the gacA mutant background (Gauthier, Jones et al. 2010), however this study did not
directly study the role of rpoS in V. vulnificus phase variation.
In V. vulnificus, it has been reported that environmental parameters such as temperature
and aeration influence capsular polysaccharide phase variation but quorum sensing, biofilm
formation, choice of media and oxidative stress do not (Hilton, Rosche et al. 2006). In addition,
previous studies in our lab have established a role for the divalent cation, calcium (Ca2+) in
modulating CPS and EPS phase variation in V. vulnificus (Garrison-Schilling, Grau et al. 2011).
The rugose phenotype may aid in survival of bacteria under adverse environmental
conditions (Costerton, Stewart et al. 1999, Davey and O'Toole G 2000, Grau, Henk et al. 2005).
V. vulnificus rugose cells have been shown to have increased resistance to serum killing (Grau,
Henk et al. 2005), chlorine stress (Guo and Rowe-Magnus 2010), and they are also very adept at
biofilm formation (Grau, Henk et al. 2005, Guo and Rowe-Magnus 2010). Biofilms are a
congregation of bacteria that can form on biotic or abiotic surfaces and are enclosed in a hydrated
matrix (Luanne, Costerton et al. 2004). Being in this community form of living endows a number
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of advantages to bacteria such as protection from biocides (Mah and O'Toole 2001), predation
(Matz, McDougald et al. 2005), osmotic and oxidative stress (Wai, Mizunoe et al. 1998), and
chlorine resistance (Yildiz and Schoolnik 1999), as well as providing increased access to nutrients
(Donlan and Costerton 2002). In 2009, Srivastava et al. demonstrated in a laboratory setting that
V. vulnificus existed primarily in the opaque phenotype in oysters while in seawater they existed
predominantly in the rugose form (Srivastava, Tucker et al. 2009).
A number of genes that affect the V. vulnificus rugose phenotype and biofilm formation
have been studied. It was demonstrated that the presence of capsule inhibits biofilm formation
(Joseph and Wright 2004). The inhibitory effect of capsule on V. vulnificus biofilm formation was
confirmed when a mutant in wbpP, an epimerase participating in capsule production, formed
significantly more biofilm than the wild type (Lee, Kim et al. 2013). Surface structures such as pili
and flagella also play a role in biofilm formation as inactivation of both pilA, a type IV pilus gene
and flaE, a flagellar hook gene reduced the biofilm forming ability of V. vulnificus (Lee, Rho et al.
2004). In silico analysis of two V. vulnificus strains have identified three EPS loci participating in
EPS production (Kim, Park et al. 2009). EPS-I has genes homologous to the symbiosis related
polysaccharide (syp) locus in V. fischeri, which was later designated as ‘rbd’ - regulation of biofilm
development - and plays a role in biofilm enhancement and aggregate formation but not in stress
resistance, and is not absolutely necessary for biofilm formation (Guo, 2011). EPS-II is a ninegene cluster, initially called wcrA-K, but then renamed brpA-K (for biofilm and rugose
polysaccharide), which encodes proteins involved in EPS biosynthesis and transport (Grau, Henk
et al. 2008, Guo and Rowe-Magnus 2010). EPS-III shows homology to a tentative cluster in V.
fischeri but its function is not yet determined. Mutations in representative genes in each of these
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clusters confirmed their involvement in V. vulnificus biofilm formation (Kim, Park et al. 2009,
Guo and Rowe-Magnus 2010, Garrison-Schilling, Kaluskar et al. 2014).
An intracellular signaling molecule, bis-(3’,-5’)-cyclic-di-GMP (c-di-GMP), has also been
shown to influence biofilm formation in V. vulnificus (Nakhamchik, Wilde et al. 2008). For
example, it has also been shown that transcription of brpA-K and their two cognate regulatory
genes, brpR and brpT, is controlled by c-di-GMP (Guo and Rowe-Magnus, 2010). On the other
hand, the rbd locus does not appear to be regulated by c-di-GMP (Guo and Rowe-Magnus, 2011).
A number of regulators also have been identified to influence the V. vulnificus biofilm
phenotype. A nitrogen regulator, ntrC, affects biofilm formation by acting as a transcriptional
activator of gmhD, an epimerase that plays a role in exopolysaccharide synthesis (Kim, Lee et al.
2007). In addition, a carbon storage regulator, csrA, has been shown to negatively regulate biofilm
formation (Jones, Warner et al. 2008). Furthermore, a quorum sensing regulator, smcR has been
shown to play a role in biofilm dissociation by upregulating the expression of VvpE, an elastolytic
protease that has been shown to dissolve biofilms (Kim, Park et al. 2013).
Only a few studies have elucidated specific environmental factors that affect biofilm
formation in V. vulnificus. Biofilm formation and EPS production was increased in a medium
containing tricarboxylic acid intermediates as a carbon source and decreased in high nitrogen
conditions. These processes were controlled by NtrC (Kim, Park et al. 2009). A previous study
from our lab has demonstrated that supplementation of the medium with Ca2+ at millimolar levels
can enhance biofilm formation in V. vulnificus (Garrison-Schilling, Grau et al. 2011).
Our overall aim in this dissertation work was to gain a deeper insight into the process of
phase variation and biofilm formation in V. vulnificus. In chapter 2, we have discussed the testing
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of various divalent cations that could induce phase variation in V. vulnificus, with an emphasis on
the role of manganese on phase variation and biofilm formation. Also, in chapter 2, we have
determined potential genetic components that are involved in V. vulnificus phase variation and
have discussed the potential role of the stationary phase regulator, rpoS in the same. In chapter 3,
we have compared the proteomic profiles of the opaque and the rugose phase variants in V.
vulnificus and have further tried to characterize the role of a MalE, a sugar binding periplasmic
protein, in V. vulnificus rugosity. In chapter 4, we have studied the distribution of EPS producing
brp genes in several V.vulnificus strains, to determine if these genes are widespread in V.vulnificus.
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CHAPTER 2
ENVIRONMENTAL AND GENETIC FACTORS CONTRIBUTING TO V.VULNIFICUS
PHASE VARIATION
INTRODUCTION
Vibrio vulnificus is a Gram-negative halophile inhabiting estuaries and marine
environments where it exists in the water column, sediments and also in the guts of filter feeders
like shrimp and oysters. Consumption of raw seafood by individuals suffering from health
conditions like diabetes, liver cirrhosis and hemochromatosis can cause gastroenteritis and
septicemia, whereas exposure of skin lesions to seafood or seawater can cause wound infections
(Oliver 2013). Pathogenesis is caused by capsule producing, opaque (O) strains (Amako, Okada
et al. 1984, Yoshida, Ogawa et al. 1985, Simpson, White et al. 1987). Under lab conditions, nonpathogenic translucent (T) colonies arise from pathogenic encapsulated strains by reduction or
total loss of capsular material (Yoshida, Ogawa et al. 1985, Simpson, White et al. 1987, Wright,
Simpson et al. 1990, Grau, Henk et al. 2005). Likewise, the translucent strains can switch to the
opaque phenotype by production of capsular polysaccharide (CPS) (Grau, Henk et al. 2005).
Additionally, production of exopolysaccharide (EPS) gives rise to the rugose (R) phenotype, which
appears dry and wrinkled on agar surface and has the ability to form copious biofilms (Grau, Henk
et al. 2005). This spontaneous change from one phenotype to another is referred to as phase
variation.
Phase variation is defined as a reversible change in phenotype accompanied by genetic or
epigenetic changes which can increase bacterial fitness, aid in survival and provide protection
against host defense (Wisniewski-Dyé and Vial 2008). Surface structures like proteins, pili,
fimbriae, flagella, LPS, capsule and exopolysaccharides have been known to phase vary (van der
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Woude and Baumler 2004). Various genetic mechanisms like site-specific recombination,
homologous recombination, insertions, deletions, slipped strand mispairing and epigenetic
mechanisms like methylation have been identified to lie at the basis of phase variation in different
organisms (van der Woude and Baumler 2004, Wisniewski-Dyé and Vial 2008). A number of
environmental factors causing phase variation have been documented as well. Pili in N.
gonorrhoeae undergo increased phase variation due to iron starvation (Serkin and Seifert 2000).
Temperature, pH, carbon source and amino acid concentration affect fimbrial phase variation in
Escherichia coli and Salmonella typhimurium (van der Woude and Baumler 2004).
In V. vulnificus, one genetic mechanism has been identified to cause the irreversible switch
from the opaque to the translucent phenotype. This mechanism involves deletions of wzb (a
tyrosine phosphatase gene participating in capsule biosynthesis), which are caused by
recombination between flanking direct repeats (Chatzidaki-Livanis, Jones et al. 2006, GarrisonSchilling, Grau et al. 2011). The switch from O and T to the R phenotype has been shown to be
accompanied by increased transcription of brp (formerly wcr) genes (Grau, Henk et al. 2008, Guo
and Rowe-Magnus 2010). Deletions in rseB, a periplasmic negative regulator of alternative sigma
factor E caused increased polysaccharide phase variation in V. vulnificus (Brown and Gulig 2009).
It has been reported in V. vulnificus that phase variation appears to be a stationary phase
phenomenon as it was speculated that decreased mRNA levels of rpoS (stationary phase sigma
factor) in a gacA (response regulator) mutant was responsible for reduced phase variation in V.
vulnificus strain CMCP6 (Gauthier, Jones et al. 2010); however, this study did not directly study
the role of rpoS in V. vulnificus phase variation.
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In V. vulnificus, it was reported that temperature and aeration influence phase variation but
quorum sensing, biofilm formation, choice of media and oxidative stress do not (Hilton, Rosche
et al. 2006). It has also been reported that tricarboxylic acid intermediates enhance biofilm
formation but higher nitrogen levels inhibit the same (Kim, Park et al. 2009). Previous studies in
our lab established a role for calcium (Ca2+) in enhancing the propensity of opaque strains to switch
to translucent and rugose variants. The calcium-induced opaque to translucent switch was
sometimes associated with deletions in the wzb gene. Calcium was also found to increase biofilm
mass; therefore, this cation appears to serve a dual role in persistence of V. vulnificus in the
environment (Garrison-Schilling, Grau et al. 2011).
It was proposed that the phase switching response of V. vulnificus to Ca2+ may have
evolved as an adaptive consequence of temporal fluctuations of this cation in estuaries (GarrisonSchilling, Grau et al. 2011). As the estuarine concentration of other cations such as barium (Ba2+),
manganese (Mn2+) and strontium (Sr2+) have also been reported to vary (Elsdon and Gillanders
2006), we tested here whether any of these could similarly affect exopolysaccharide phase
variation in V. vulnificus. We found that Mn2+ also dramatically increases the frequency of phase
switching. While some strains switched predominantly to the same variant type in both Ca2+ and
Mn2+, the phenotypic effects of Ca2+ and Mn2+ on other strains were different. We also have
attempted to study the role of wzb gene deletions and the rpoS gene in manganese-induced phase
variation. Lastly, we provide evidence that Mn2+, like Ca2+, increases biofilm formation in this
species.
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RESULTS
Identification of manganese as an additional cation that promotes phase variation in
V. vulnificus. Previously, we found that supplementation of LB2 broth with 1 mM Ca2+ (LB2+Ca)
caused a significant increase in switching of opaque strains to translucent and rugose isolates
(Garrison-Schilling, Grau et al. 2011). In a similar manner, here we assessed the addition to LB2
of 1 mM Ba2+ (LB2+Ba), 1 mM Mn2+ (LB2+Mn) or 1 mM Sr2+ (LB2+Sr) on phase variation of
opaque strain 1003(O). As previously described, our switching assays involved daily passaging
of strains in the medium of choice with plating for individual colonies following a certain number
of passages (e.g., 5) and subsequent enumeration and scoring of colonial phenotypes (GarrisonSchilling, Grau et al. 2011).
After 5 passages in LB2+Mn, 70.4 ± 25.9 % of strain 1003(O) colonies had switched to
the translucent phase while 10.5 ± 9.3 % of the colonies remained opaque, 0.7 ± 0.4 % were
sectored and 18.4 ± 16.9 % were of an indeterminant phenotype. These results contrasted
substantially with LB2 alone, where only 0.1 ± 0.1 % of colonies had switched to the translucent
phase after 5 passages with 99.9 ± 0.1 % remaining opaque. Using a linear mixed models ANOVA
analysis and a significance cutoff of P < 0.05, the percentage of colonies that switched to
translucent in LB2+Mn was significantly greater (P = 0.0002) than the percent that switched to
this phenotype in LB2 alone. The percentage of translucents in LB2+Mn was comparable and not
significantly different (P = 0.1360) from the percent seen in LB2+Ca (44.6 ± 21.1 %). In contrast
to the results for LB2+Mn, no switching of 1003(O) was observed after 5 passages in LB2+Ba,
and switching in LB2+Sr occurred predominantly to the rugose phenotype at passage 5 (7.5 ± 13.0
%, Figure. 2.1), though this was judged not to be significant (P = 0.6418).
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Figure 2.1: Evidence that Mn2+ promotes exopolysaccharide phase variation in V. vulnificus.
Switching assays were performed for 5 passages for strain 1003(O) in LB2, LB2+Ba, LB2+Ca,
LB2+Mn, and LB2+Sr. Dilutions and platings of the initial overnight (ON) culture and following
5 passages were conducted in order to count and score colony phenotypes. The proportion of
opaque (O), translucent (T) and rugose (R) colonies were calculated for 3 independent experiments
and the means ± SD are presented.

During the course of these switching assays we noticed that strain 1003(O) grew at a visibly
slower rate in LB2+Mn than LB2 alone. This observation was confirmed by growth curves in the
two media (Figure 2.2), which showed a significant difference in mean OD600 at all time-points
tested for 1003(O) (max P = 0.0029). We wondered whether the increased appearance of
translucent isolates in LB2+Mn was related in any way to the slower growth rate of 1003(O) in
this medium.
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Figure 2.2: Growth curves of strain 1003(O) and a translucent derivative in LB2, LB2+0.2Mn,
LB2+Mn. At least 5 independent replicates were performed and OD600 values were averaged at
each time point. Error bars indicate SD.

To address this possibility, we sought to compare rates of phase variation in LB2+Mn
versus LB2 containing a lower concentration of Mn2+ that would not slow down the growth of
strain 1003(O). Previous results with Streptococcus mutans showed growth inhibition of that
organism in Mn2+ concentrations greater than 0.2 mM (Arirachakaran, Luengpailin et al. 2007),
prompting us to test LB2 supplemented with 0.2 mM Mn2+ (LB2+0.2Mn) as the additional
medium. In switching assays of strain 1003(O) in LB2, LB2+0.2Mn and LB2+Mn, it was found
that, after 5 passages in LB2+0.2Mn, 84.9 ± 14.2 % of colonies had switched to translucent and
0.6 ± 0.4 % had become rugose, leaving only 13.1 % ± 12.7 % as opaque (Figure. 2.3).
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Figure 2.3: Comparable increases in phase variation in the presence of 1 mM and 0.2 mM Mn2+.
Switching assays for strain 1003(O) were conducted in LB2, LB2+0.2Mn, and LB2+Mn for 5
passages. Dilutions and platings were performed as described in Figure. 2.1. The proportion of
each phenotype was calculated for 3 independent experiments and the means ± SD are presented.

This percentage of translucent and rugose colonies was significantly different (P < 0.0001)
from that seen in LB2 where 98.6 % ± 0.6 % of colonies remained opaque after 5 passages, but it
was not statistically different from LB2+Mn (P = 0.2466), where after 5 passages 97.5 ± 2.2 %
and 0.3 ± 0.6 % colonies had switched to translucent and rugose, respectively.
An examination of growth curves (Figure 2.2) for strain 1003(O) in LB2+0.2Mn versus
LB2 revealed no significant differences for the majority of time points (data not shown). Since
the percent of translucent and rugose colonies obtained in LB2+0.2Mn and LB2+Mn was
comparable (Figure 2.3), it appeared that the enhanced phase variation seen in LB2+Mn was
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unrelated to the slow growth observed in this medium. Though slower growth in 1 mM Mn2+ could
be due to the toxic effects of this divalent cation on V.vulnificus, our data suggests that 0.2 mM
Mn2+ seems to be sufficient for phase variation. An additional comparison of growth curves
(Figure 2.2) in LB2+0.2Mn for 1003(O) and a translucent derivative (i.e., strain 1003[T], isolated
in switching assays in LB2+Mn) indicated that, for the majority of time points, either 1003(O)
grew significantly better than 1003(T) or there was no significant difference between them (data
not shown). No significant differences were also seen at the majority of time points for these two
strains in LB2+Mn (data not shown). These latter observations suggest that the increased
appearance of translucent colonies following growth of 1003(O) in media with elevated [Mn2+]
results mainly from an increased propensity for phase variation rather than a growth advantage for
the resulting translucent derivatives.
Comparison of phenotypic effects for increased [Ca2+] versus [Mn2+] among V.
vulnificus strains. Increased Ca2+ was shown to promote switching of some V. vulnificus opaque
strains to predominantly the translucent phenotype (e.g., strain 1003[O]) while others switched to
the rugose phase (Garrison-Schilling, Grau et al. 2011). Here, we found that Mn2+ also induced
switching of 1003(O) to mainly the translucent phenotype (Figures 2.1 and 2.3). To further
compare the effects of equimolar increases in Mn2+ and Ca2+, we subjected additional V. vulnificus
opaque strains to switching assays and representative results are presented here. Opaque strain
MLT124, which previously switched predominantly to rugose in LB2+Ca, showed the same
expected pattern here in this medium (Figure 2.4). MLT124 also switched mainly to rugose in
LB2+Mn, although the percent switching in LB2+Mn relative to LB2 alone was not significant by
5 passages. When the assay was extended out to 15 passages, 42.1 ± 30.0 % of MLT124 colonies
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had become rugose in LB2+Mn as compared to only 2.5 ± 4.3 % in LB2 (Figure 2.4), and the
percent switching in these two media was considered to be significantly different (P = 0.0242).

Figure 2.4: Enhanced phase switching from opaque to predominantly rugose for strain MLT124 in
the presence of increased [Mn2+]. Switching assays were performed in LB2, LB2+Mn and LB2+Ca
for 15 passages. Dilutions and platings were done on the ON culture and after 5, 10 and 15
passages. The proportion of each phenotype was calculated for 3 independent experiments and
the means ± SD are presented.

It was previously demonstrated that opaque strain C7184 predominantly switched to
translucent colonies in LB2+Ca at the end of 10 passages. The presence of manganese also induced
a switch from opaque to 44.0 ± 27.3 % T phenotype after 5 passages, which was significant
(P<0.0001) in comparison to LB2 where colonies remained nearly 99 % opaque at this point
(Figure 2.5).
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% colonies
Figure 2.5: Enhanced phase switching from opaque to predominantly translucent for strain C7184
in the presence of increased [Mn2+]. Switching assays were performed in LB2, LB2+Mn and
LB2+Ca for 5 passages. Dilutions and platings were performed as described in Figure 2.1. The
proportion of each phenotype was calculated for 6 independent experiments and the means ± SD
are presented.

As previously observed in LB2+Ca, opaque strain YJ016 switched to predominantly
translucent colonies in LB2+Mn. Though switching to 6.3 ± 9.0 %, 20.1 ± 15.2 % and 24.3 ± 8.6
% translucent colonies was observed after passages 5, 10 and 15, respectively, in 1 mM Mn2+
(Figure 2.6), this switching was not deemed statistically significant according to our analysis
despite the fact that colonies in LB2 remained more than 96.4 % opaque at all passages.
Contrasting phenotypic effects for Ca2+ and Mn2+ could also be demonstrated. In LB+Ca,
opaque strain MLT136 switched predominantly to rugose previously and here (Figure 2.7), while
66.5 ± 7.8 % of MLT136 colonies instead switched to translucent after 5 passages in LB2+Mn
(Figure 2.7); this amount was deemed significant in comparison to the LB2 control (P < 0.0001).
23

LB2

120.0%

passage 5

ON

passage 10

passage 15

LB2+Ca
LB2+Mn

% colonies

100.0%
80.0%
60.0%
40.0%
20.0%
0.0%
O

T

R

O

T

R

O

T

R

O

T

R

colony phenotype
Figure 2.6: Phase switching from opaque to predominantly translucent for strain YJ016 in the
presence of increased [Mn2+]. Switching assays were performed in LB2, LB2+Mn and LB2+Ca
for 15 passages. Dilutions and platings were done on the ON culture and after 5, 10 and 15
passages. The proportion of each phenotype was calculated for 3 independent experiments and
the means ± SD are presented.

Figure 2.7: Enhanced phase switching from opaque to predominantly translucent for strain
MLT136 in the presence of increased [Mn2+]. Switching assays were performed in LB2, LB2+Mn
and LB2+Ca for 5 passages. Dilutions and platings were performed as described in Figure 2.1.
The proportion of each phenotype was calculated for 3 independent experiments and the means ±
SD are presented.
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It was previously observed that opaque strain CPSed5 switched predominantly to rugose
colonies in LB2+Ca and the same pattern was observed here in the same medium. However it
switched largely to translucent colonies at passages 10 (12.7 ± 14.2 %) and 15 (64.5 ± 33.1 %) in
media supplemented with manganese. Compared to the LB2 control, this effect was significant at
passage 15 only (P= 0.0117) (Figure 2.8).
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Figure 2.8: Enhanced phase switching from opaque to predominantly translucent for strain CPSed5
in the presence of increased [Mn2+]. Switching assays were performed in LB2, LB2+Mn and
LB2+Ca for 15 passages. Dilutions and platings were done on the ON culture and after 5, 10 and
15 passages. The proportion of each phenotype was calculated for 3 independent experiments and
the means ± SD are presented.

As with strain 1003(O), the other strains examined here grew noticeably slower in LB2 +
Mn. For example, both MLT124 and MLT136 grew significantly slower (max P< 0.0001)
throughout growth in LB2+Mn versus LB2 (Figures 2.9a and 2.9b, respectively). Interestingly, a
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rugose isolate of MLT124 (i.e., MLT124[R]) grew significantly better (max P = 0.0004 at time 4
h and beyond) than MLT124 in LB2+Mn (Figure 2.9a), while there was no significant difference
(data not shown) at the majority of time points between MLT136 and its translucent derivative,
MLT136(T), in that same medium (Figure 2.9b). Taken together, our results here support the
notion that Mn2+ increases the frequency of phase switching of opaque V. vulnificus strains to the
translucent or rugose states, though a selective growth advantage for resulting phase variants of
certain strains may also be a contributing factor in their appearance.

(a)

Figure 2.9: Growth curves of strains (a) MLT124 and a rugose derivative, (b) MLT136 and a
translucent derivative in LB2 and LB2+Mn. At least 5 independent replicates were performed and
OD600 values were averaged at each time point. Error bars indicate SD.
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(b)

(Figure 2.9 continued)

Genetic basis of opaque to translucent switch involves genetic changes in the wzb gene.
Deletions in the wzb gene, which functions as a tyrosine phosphatase during capsule biosynthesis,
have been demonstrated to be involved in the irreversible switch from opaque to translucent
phenotypes in V. vulnificus (Chatzidaki-Livanis, Jones et al. 2006). It was also shown by Garrison
et al. that deletions in the wzb gene are associated with phase switching of opaque to translucent
phenotypes observed upon calcium supplementation (Garrison-Schilling, 2011). To determine if
deletions in wzb are also associated with Mn2+ induced phase switching, PCR’s were performed
using wza-For and wzc-Rev primers as mentioned (Garrison-Schilling, 2011). Genomic DNA
from 13 T phase variants of different strains obtained during switching assays in LB2+0.2 Mn and
LB2+Mn were used as a template. Nine of the phase variants amplified the 1.4-kb wild type band.
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One of the phase variants amplified a 0.85 kb band, which indicated a deletion event, and two of
the remaining strains did not amplify any bands indicating complete deletion of wzb or mutations
in the primer binding regions. Additionally, one of the phase variants amplified a 3.0 kb band
indicating a duplication or an insertion event (Table 2.1).

Table 2.1: wzb gene region PCR band sizes in translucent variants obtained during switching
assays in LB2 supplemented with manganese.

Strain

wzb band size (kb)

1003-T8

1.40

1003-T9

1.40

1003-T10

1.40

1003-T11

1.40

1003-T12

1.40

1003-T13

1.40

1003-T14

1.40

1003T-15

0.85

MLT124-T6

1.40

MLT124-T7

1.40

MLT136-T7

3.00

MLT136-T8

No band

MLT136-T9

No band
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Role of rpoS in V. vulnificus phase variation. A study determining the factors influencing
capsular polysaccharide phase variation in V. vulnificus suggested that rpoS, which encodes a
sigma factor important for the stationary phase stress response, may be involved (Hilton, 2006).
Also, Gauthier et al. (Gauthier, 2010) speculated that reduction in the levels of rpoS mRNA
transcript in a gacA response regulator mutant strain results in a reduction in phase variation of V.
vulnificus. Our switching assay procedure for determination of phase variation involves incubating
passaged cultures for 18-24 hours before plating. Since V. vulnificus reaches stationary phase by
approximately 6 hours (unpublished data), we hypothesized that rpoS may participate in Ca2+- and
Mn2+-induced phase variation in V. vulnificus. Previous studies in our lab indicated that, while
strain C7184 readily underwent phase variation in the presence of calcium, its rpoS mutant
derivative AH1 (Hulsmann, Rosche et al. 2003) did not. Here we wanted to test whether rpoS was
involved in Mn2+-induced phase variation as well. Switching assays performed on C7184 and AH1
in the presence of LB2 and LB2+Mn indicated that both showed an ability to switch to the
translucent phase though the mutant appeared to do so at a reduced frequency (Figure 2.10a, b).
We attempted to determine if complementation of rpoS in trans in strain AH1 would restore
its phase variation capability back to the level seen for C7184. Plasmid pVV70, which contains
the rpoS gene of C7184 cloned onto vector pBBRAD2kan, was introduced into strain AH1 to
create AH1-C. Similarly, the empty vector pBBRAD2kan was introduced to create strain AH1/
pBBRAD2kan.
Switching assays were then performed on strains AH1-C and pBBRBAD2Kan/AH1 in the
presence of LB2 and LB2+Mn. rpoS gene expression on pVV70 was induced by adding 0.2 %
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arabinose to the medium. Unexpectedly, the AH1-C did not show increased phase variation
relative to AH1 or AH1/ pBBRAD2kan (Figure 2.10).
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Figure 2.10: Role of rpoS in Ca2+ and Mn2+ induced V. vulnificus phase variation. Switching assays
were performed on (a) C7184, (b) AH1, (c) AH1-C, (d) AH1/pBBRBAD2Kan in LB2, LB2+Ca,
LB2+Mn supplemented with 0.2 % arabinose and antibiotics as required. Switching assays were
carried out for a total of 15 passages. Phase variation was assayed by dilution and plating of the
ON, 5, 10 and 15 passages and data presented here are means and std. deviations of 3 independent
experiments.
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(Figure 2.10 continued)

Prior to switching assays, growth curves were performed on C7184, AH1, AH1-C and
AH1/ pBBRAD2kan in LB2, LB2+Ca and LB2+Mn supplemented with 0.2 % arabinose and the
respective antibiotics. The growth of all of these strains was very similar in LB2 and LB2+Ca.
However, as expected, all these strains grew slower in 1 mM Mn2+ (Figure 2.11).
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Figure 2.11: Growth curves on C7184, AH1, AH1-C and AH1/pBBRBAD2Kan in LB2, LB2+Ca,
LB2+Mn supplemented with the appropriate antibiotics and 0.2 % arabinose. At least 5
independent replicates were performed and OD600 values were averaged at each time point. Error
bars indicate SD.

These results could mean that there is a potential problem with rpoS expression from the
complementation system employed. A future experiment integrating rpoS under the control of its
own promoter into the AH1 chromosome before performing switching assays on this strain should
be conducted.
Assessment of the ability of manganese to enhance biofilm formation in V. vulnificus.
Previously, we observed that an elevated [Ca2+] concentration promoted both phase variation and
biofilm production in V. vulnificus (Garrison-Schilling, Grau et al. 2011). The potential effect of
increased [Mn2+] on biofilm formation of representative V. vulnificus strains was assessed here
using standard assays which involved crystal violet staining, extraction and quantification of
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rugose strains KG3(R) & BG(R) biofilms from cultures grown in LB2, LB2+Ca, and LB2+Mn
media. Supplementation of LB2 with Mn2+ increased biofilm formation of KG3(R) by 7.2 fold
relative to the LB2 control, an effect that appeared similar to the 9.3-fold enhancement observed
for LB+Ca (Table 2.2). The increased biofilm mass seen here in LB2+Mn and LB2+Ca compared
to LB2 alone were both deemed significant (both P < 0.0001). Despite the significant increase in
biofilm formation for strain KG3(R) in LB2+Mn, this enhancement was statistically lower (P =
0.0095) than the increase seen for KG3(R) in LB2+Ca (Table 2.2).
Enhanced biofilm production in the presence of increased [Mn2+] was also qualitatively
observed for strain BG(R) where a 3.7 fold increase was observed in biofilm formation compared
to LB2; however, this increase was not deemed to be statistically significant (P=0.1682). As
expected, strain BG(R) showed a significant enhancement of biofilm formation in the presence of
LB2+Ca compared to LB2 (P<0.0001) (Table 2.2).

Table 2.2: Mn2+ enhances biofilm formation in V. vulnificus. Biofilm assays were performed on
strains BG(R) and KG3(R) by measuring absorbance of extracted CV at OD570 and multiplying by
the dilution factor, if necessary. Data shown here are means and standard deviations from three
trials with at least 5 experiments conducted in each trial. Ratios were calculated by dividing mean
OD570 value in a particular media by mean OD570 value in LB2. a Ratio for biofilm formation in
LB2+Ca. b Ratio for biofilm formation in LB2+Mn.

Biofilm formation (OD570 of CV)
Strain

Ratioa Ratiob

LB2

LB2+Ca

LB2+Mn

±SD

±SD

±SD

BG(R)

0.15 ± 0.05

2.64 ± 0.96

0.57 ±0.53 17.20

3.70

KG3(R)

0.19 ± 0.09

1.72 ± 0.61

1.33 ± 0.33

7.20
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9.30

DISCUSSION
Here we have demonstrated that phase variation of either CPS or EPS production in V.
vulnificus is responsive to an additional environmental signal, which is manganese. We previously
postulated that phase switching of opaque V. vulnificus variants to either translucent or rugose may
be an adaptive consequence of the temporal variability in [Ca2+] that has been documented in
estuaries (Garrison-Schilling, Grau et al. 2011). As estuarine Mn2+ concentrations are also known
to vary, a similar argument can be made for the observed response to this cation. Unlike Ca2+,
however, Mn2+ concentrations measured in estuarine waters were well below the millimolar range
that we used in our studies (Elsdon and Gillanders 2006, Azlisham, Vedamanikam et al. 2009);
nevertheless, it is noteworthy that temporal fluctuations of Mn2+ in the millimolar range has been
documented in both sediment and oyster samples from coastal areas (Azlisham, Vedamanikam et
al. 2009).
Ca2+ promotes biofilm formation in V. vulnificus (Kierek and Watnick 2003a, GarrisonSchilling, Grau et al. 2011). Though, the molecular mechanism of biofilm formation by Ca2+ has
not yet been elucidated, Ca2+ has been proposed to act as a sensory ion which regulates gene
expression of biofilm associated components in some organisms, while in others a structural role
for Ca2+ in the biofilm matrix has been proposed (Patrauchan, Sarkisova et al. 2005). Kierek and
Watnick (Kierek and Watnick, 2003a) provided compelling evidence that Ca2+ is an integral
component of one type of biofilm produced by Vibrio cholerae, perhaps forming intercellular salt
bridges between cell-associated components. An analogous role for Ca2+ in biofilm formation of
other Vibrio spp., including V. vulnificus, was also postulated (Kierek and Watnick 2003a,
Garrison-Schilling, Grau et al. 2011). Several lines of evidence make it tempting to speculate that
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Mn2+ is also capable of serving a similar structural role in biofilm formation in bacteria. In S.
mutans, Mn2+ promoted formation of non-sucrose biofilms, which showed greater biomass,
substratum occupation, thickness, and roughness than biofilms formed in the absence of Mn2+
(Arirachakaran, Luengpailin et al. 2007). It was also reported that dental plaques had orders of
magnitude greater concentrations of Mn2+ than that found in saliva (Arirachakaran, Luengpailin et
al. 2007). Kierek and Watnick (Kierek and Watnick 2003a) also noted that while pre-formed Ca2+dependent biofilms of V. cholerae rapidly dissolved in media lacking Ca2+, this dissolution was
slowed when the media was amended with Mn2+. Taken together with our results here, it is
possible that Mn2+ can play a role in biofilm structuring, although alternative or additional roles
such as affecting relevant gene expression can also be imagined.
There are now several examples of Vibrio spp. responding to cations normally present in
their marine environments. In addition to the effects of Mn2+ and Ca2+ on phase variation in V.
vulnificus, magnesium was found to enhance flagellation in V. fisheri (O'Shea, Deloney-Marino et
al. 2005).

Calcium and iron (Fe2+) also affected swarming and type III secretion in V.

parahaemolyticus (Gode-Potratz, Chodur et al. 2010). In the latter case, regulons of genes
responsive to Ca2+ and Fe2+ were revealed and a transcriptional regulator was identified which
promotes Ca2+-regulated gene expression.
The underlying mechanism(s) of how Mn2+ promotes phase variation in V. vulnificus
remains to be fully elucidated. Manganese homeostasis in bacteria is maintained by regulated
transport systems, and Mn2+ metalloenzymes that participate in numerous metabolic pathways
(e.g., glycolysis, gluconeogenesis, amino acid metabolism), as well as other important functions,
including signal transduction and the oxidative stress response (Jakubovics and Jenkinson 2001).
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Manganese-regulated transcriptional control has also been documented, perhaps most notably by
the Fur metallorepressor protein, which binds Fe2+ or Mn2+ to regulate numerous target genes in a
variety of Gram-negative bacteria, including Vibrio spp. (Troxell and Hassan 2013). Our data from
the wzb gene deletions indicate that even though this mechanism may be one of the means of phase
variation there does exist at least one other mechanism which brings about the switch from O to T
phenotype since some of the T isolates characterized had no apparent deletion of this genetic
region. Additionally, our results showing the rpoS mutant undergoing phase variation in the
presence of Mn2+ at an apparent reduced frequency compared to the wild type parent implies a role
for the rpoS gene in V. vulnificus but this needs further experimentation. In Pseudoalteromonas
sp. PCL1171, phase variation between the opaque and translucent phenotypes is dependent on
spontaneous mutations in the regulatory genes, gacA & gacS. Constitutive expression of rpoS in
this organism increases the frequency at which gac mutants appear by 10 fold (van den Broek,
Chin et al. 2005). Elucidation of the pathway(s) by which Mn2+ (and Ca2+) promotes colonial phase
variation in V. vulnificus will provide further insight into how this marine inhabitant and human
pathogen persists and responds to changing environmental conditions.
MATERIALS AND METHODS
Strains and growth conditions: V. vulnificus strains were stored at -70°C in heart infusion
broth, (Difco) supplemented to a total of 2% NaCl (HI) with 15 % glycerol added. Frozen stocks
were streaked on HI agar supplemented with 18g/L non- granulated agar (Difco) for single colony
isolation. Plates were incubated at 30°C overnight (ON) for 16-24 hours and broth cultures were
grown at 30°C ON for 16-24 hours with shaking at 200 rpm. E. coli strains were stored at -70°C
in Luria-Bertani (LB) broth (Difco) supplemented with 20 % glycerol and they were streaked on
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LB agar supplemented with 15 g/L granulated agar (Difco) for single colony isolation. Plates were
incubated at 37°C ON for 16-24 hours and broth cultures were grown at 37°C and 250 rpm ON
for 16-24 hours. V. vulnificus switching assays and growth curves were carried out in LB2 (LB
broth supplemented to a total of 2 % NaCl), LB2+Ba (LB2 supplemented with 1 mM BaCl2.2H2O),
LB2+Ca (LB2 supplemented with 1 mM CaCl2.2H2O), LB2+0.2Mn (LB2 supplemented with 0.2
mM MnCl2.6H2O), LB2+Mn (LB2 supplemented with 1 mM MnCl2.6H2O) and LB2+Sr (LB2
supplemented with 1 mM SrCl2.6H2O). All experiments were conducted at least in triplicate in the
above media at 30°C.
Antibiotics (Sigma) were used as follows when needed: 50µg/ml ampicillin, 10µg/ml
chloramphenicol and 150µg/ml kanamycin for V. vulnificus and 50µg/ml ampicillin, 2µg/ml
chloramphenicol and 50µg/ml kanamycin for E. coli. Arabinose (Sigma) and IPTG (Sigma) were
added to a final concentration of 0.2 % and 1 mM respectively as required. Strains and plasmids
used in this study are listed in Tables 2.3 and 2.4 respectively.

Table 2.3: Strains used in the study
Strain

Description

Source or reference

V. vulnificus
1003(O)

formerly 1003; opaque wound isolate

(Martin and Siebeling 1991)

from Louisiana
1003(R)

spontaneous rugose phase variant of 1003(O)

This study

from LB2+Mn
1003(T)

spontaneous translucent phase variant of 1003(O)
from LB2+Mn
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This study

(Table 2.3 continued)
Strain

Description

Source or reference

AH1

C7184 rpoS::pHA4; rpoS deficient

AH1-C

AH1 containing rpoS on pBBRBAD2Kan, Kanr

This study

AH1/pBBBRBAD2Kan AH1 containing pBBRBAD2Kan vector control

This study

(Hulsmann, Rosche et al. 2003)

transformed into AH1
BG(R)

spontaneous rugose phase variant of 1003(O)

C7184

clinical opaque isolate

CPSed5

sediment isolate

KG3(R)

spontaneous rugose phase variant of

(Grau, Henk et al. 2005)

(Hulsmann, Rosche et al. 2003)
(Garrison-Schilling, Grau et al. 2011)
(Garrison-Schilling, Kaluskar 2014)

YJ016
MLT124(O)

oyster isolate, opaque

(Garrison-Schilling, Grau et al. 2011)

MLT124(R)

spontaneous rugose from MLT124(O)

This study

in LB2+Mn
MLT124(T)

spontaneous translucent from MLT124(O)

This study

in LB2+Mn
MLT136(O)

oyster isolate, opaque

(Grau, Henk et al. 2005)

MLT136(R)

spontaneous rugose from MLT136(O)
in LB2+Ca

MLT136(T)

(Garrison-Schilling, Kaluskar2014)

spontaneous translucent from MLT136(O)

This study

in LB2+Mn
YJ016

clinical isolate, opaque

(Chen, Wu et al. 2003)

E.coli
BRL2288

F- araD139 ∆(ara-leu)7679 ∆(Fabretti, Theilacker et al.)X74
galU galK hsdR2 (rκ- mκ-) mcrB1 rpsL
recA56 (Strr)
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(Brasch, Pettis et al. 1993)

(Table 2.3 continued)
Strain

Description

S17.1

thi pro hsdR hdsM+ recA

Source or reference
(Simon, Priefer et al. 1983)

RP4-2-Tc::Mu-Km-Tn7
S17.1λpir

(Simon, Priefer et al. 1983)

thi pro hsdR hdsM+
recA RP4-2-Tc::Mu-Km-Tn7Λpir

Table 2.4: Plasmids used in this study
Plasmids

Description

Source

Vectors
pBBRBAD2

expression vector containing (Garrison-Schilling, Kaluskar 2014)
pBAD promoter and araC gene, Chlr

PBBRBAD2Kan

expression vector containing pBAD

This study

promoter, Kanr, Chls
pSP72

cloning vector, Ampr

Promega

Complementation clones
pVV68

rpoS cloned into pSP72, Ampr

This study

pVV70

rpoS cloned into pBBRBAD2Kan, Kanr

This study
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Switching assays: Single isolated colonies were first inoculated and grown in the
respective medium overnight for 16-24 hours with shaking at 200 rpm. This culture was termed
ON. ON cultures were subcultured 1:100 into 3 ml of the respective media being tested for a total
of 15 days. Each subculture was termed a passage. Occurrence of phase variation was assayed by
plating serial dilutions of each culture onto LB2 agar after ON and after every fifth passage.
Phenotypes were scored as opaque (O)- capsule producing colonies, translucent (T)- colonies with
no capsule production, rugose (R)- dry wrinkled colonies, sectored (S)- two phenotypes in one
colony, and others (Ot)- colonies which exhibit any other phenotype not categorized above.
Percent switching frequencies were calculated as the ratio of the number of colonies of a particular
phenotype divided by the total number of colonies counted for that particular passage, which is
then multiplied by 100 %.
Growth curves: Single isolated colonies were first inoculated into the respective medium
and cultures were grown overnight at 30°C for 16-24 hours with shaking at 200 rpm. The ONs
were then diluted to an optical density (OD600) of 0.01 in 5 mL of the appropriate fresh medium
and grown at 30°C and 200 rpm for 24 hours. OD600 was measured at 2,4,6,9 and 24 hours. The
24-hour cultures were streaked on LB2 agar to determine if switching had occurred.
Biofilm assays: Single isolated colonies were first inoculated into LB2, LB2+Mn and
LB2+Ca overnight for 16-24 hours with shaking at 30°C and 200 rpm. These ON’s were then
diluted to an OD600 of 0.02 into 1 ml of the media being tested. Cultures were incubated stationary
at 30°C for 48 hours. The liquid cultures were then poured off and the aggregate ring formed was
washed and stained with crystal violet. Biofilm formation was assessed by measuring OD570 of the
extracted crystal violet in dimethyl sulfoxide (Mallinckrodt).
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Genetic analysis of the wzb gene: Genomic DNA was extracted from a total of 13
translucent phase variants of 1003(O), MLT124 and MLT136 obtained during switching assays in
LB2+0.2Mn and LB2+Mn using PureGene DNA isolation kit (Gentra). Polymerase chain
reactions

(PCRs)

were

then

performed

by

using

primers

wza-For

(5′-

GGTGCTCTACGCGTTAAAACG-3′) and wzc-Rev (5′-GAGTTATCAACGGAAGATCGG-3′)
to amplify wzb and adjacent direct repeats as described previously (Garrison-Schilling, Grau et al.
2011). Briefly, 100 ng of gDNA was added to a 25 µl reaction consisting of 2.5 µl 10X PCR buffer,
10 % DMSO, 2 µl 10 mM total DNTPs, 1.5 µl 25 mM MgCl2, 1.25 µl each of 20 µM primers and
0.2 µl of 5U/ µl Amplitaq. PCR reactions were performed as follows: initial denaturation at 94°C
for 1 min, followed by 35 cycles of 94°C for 1 min, 55 °C for 1 min, and 72 °C for 2 min, with a
final extension of 72°C for 5 min. PCR products were then analyzed on a 0.7 % 1X TAE agarose
gel after running for 45 min at 80 V.
Generation of a complementation vector:

The 6,414-bp kanamycin-resistant,

chloramphenicol-sensitive plasmid pBBRBAD2Kan was created by cloning the 840 bp SmaI
kanamycin-resistance cassette from pACW29 (Wright, Powell et al. 2001) into the AclI and AseI
sites of plasmid pBBRBAD2, which was blunt ended by filling in the 5′ overhangs using Klenow
exo-. Primers RpoS up PstI (5′-AAAAACTGCAGTGCTAACTCGCCATGGGGAG-3′) and RpoS
dn XbaI (5′-AAAAATCTAGAGCCAAGCGTTAGAAGCCCTA-3′) were used to amplify C7184
gDNA to yield a 1,159 bp product, which was then digested with PstI and XbaI and cloned into
corresponding sites on pSP72 to generate plasmid pVV68. This plasmid was maintained in E.coli
strain S17.1λpir. The 1,139-bp PstI-XbaI fragment containing the rpoS gene was then lifted from
pVV68 and cloned into these sites on pBBBRAD2Kan, resulting in plasmid pVV70. This plasmid
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was maintained in strain E.coli strain BRL2288. For conjugation, pVV70 was transformed into
E.coli strain S17.1 and matings between S17.1 harboring the pVV70 and the V. vulnificus rpoS
mutant AH1 were carried out on filter membranes and kanamycin- resistant transconjugants were
subsequently selected. Complementation was induced by adding 0.2% arabinose to the media.
Statistical analysis: Data generated in the switching assays, growth curve experiments and
biofilm assays were analyzed using linear mixed models analysis of variance techniques (Littell,
Milliken et al. 2006). SAS® 9.3 was used to perform all the analyses. Analysis of each data set
involved multifactor treatment structures with repeated measures design structures (Milliken and
Johnson 1998). For growth curve experiments, the time intervals over which repeated measures
were taken were unequally spaced, whereas for the switching assays they were equally spaced. In
order to account for the potential correlation induced by the taking of repeated measurements,
random effects or covariance structures were incorporated into the statistical models, as
appropriate and as needed. In order to maintain some level of control over the overall Type-I error
rate in analyzing data for a particular experiment, overall tests were performed first. Follow-up
tests for making specific comparisons were performed only when the overall tests indicated that
differences existed among the various treatment levels. For all statistical analyses performed, P <
0.05 was considered to be statistically significant.
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CHAPTER 3
COMPARATIVE PROTEOMIC ANALYSIS OF THE OPAQUE AND RUGOSE PHASE
VARIANTS OF V. VULNIFICUS
INTRODUCTION
Vibrio vulnificus is a Gram-negative bacterium inhabiting saline environments around the
world. It can exist in the sea or in estuarine locales where it is present in the water column, or in
the sediment. It may be attached to plankton, or reside within filter feeding mollusks and other
seafood. V. vulnificus is a human pathogen that is associated with the highest mortality rate among
seafood-associated pathogens (Linkous and Oliver 1999, Strom and Paranjpye 2000).
Consumption of raw seafood such as oysters, by people with underlying conditions such as
hemochromatosis, diabetes and alcoholism may result in septicemia, whereas exposure of wounds
to sea food drippings or contaminated water can cause wound infections which in severe cases
may lead to amputation (Linkous and Oliver 1999, Strom and Paranjpye 2000, Oliver 2012).
Pathogenicity correlates with the production of capsular polysaccharide (CPS), which
imparts a smooth, opaque (O) colonial phenotype (Amako, Okada et al. 1984, Yoshida, Ogawa et
al. 1985, Simpson, White et al. 1987). Loss of CPS production imparts a smooth translucent (T)
colonial phenotype, rendering the organism attenuated for virulence, or avirulent (Yoshida, Ogawa
et al. 1985, Simpson, White et al. 1987, Zuppardo and Siebeling 1998). Furthermore, production
of exopolysaccharide (EPS) by the O and T phenotypes results in a dry, wrinkled rugose (R)
phenotype which has the ability to form copious biofilms (Grau, Henk et al. 2005, Grau, Henk et
al. 2008). In nature, microorganisms are not typically present as dispersed single cells but are
known to survive attached to surfaces as parts of biofilms, which are a conglomeration of microbes
enclosed in polysaccharide matrix, proteins and nucleic acids. The biofilm structure helps in
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sequestering nutrients, provides resistance to toxins and protects cells from grazing and
unfavorable conditions, thereby enhancing survival (Flemming and Wingender 2010).
Interestingly in oysters, V. vulnificus has been shown to exist mostly in the opaque phenotype but
in seawater it survives primarily as rugose (Srivastava, Tucker et al. 2009).
In V. vulnificus several genes have been demonstrated to play a role in biofilm formation.
Mutations in genes such as pilA, encoding pilus (Paranjpye and Strom 2005), flaE, encoding
flagella, (Lee, Rho et al. 2004) and brp as well as rbd, functioning in polysaccharide biosynthesis
and transport (Guo and Rowe-Magnus, 2010, Guo and Rowe- Magnus, 2011), have resulted in
reduced biofilm formation. An intracellular signaling molecule, bis-(3’,-5’)-cyclic-di-GMP (c-diGMP), has also been reported to enhance V. vulnificus biofilm formation (Nakhamchik, Wilde et
al. 2008). Transcriptional regulators including ntrC, a nitrogen regulator (Kim, Lee et al. 2007),
csrA, a carbon storage regulator (Jones, Warner et al. 2008), smcR, a transcriptional regulator
(Kim, Park et al. 2013), have also been shown to influence V. vulnificus biofilm formation.
The purpose of this chapter’s research was to gain a deeper insight in the process of phase
variation and rugose colony formation in V. vulnificus, by comparing the whole cell proteomic
profile differences between the O and R phase variants using two-dimensional gel electrophoresis
(2DGE) in conjunction with mass spectrometry (MS). Twenty eight proteins were found to be
differentially expressed between the O and the R phenotypes, and the role of one protein, maltose
binding periplasmic protein (MalE) was investigated further by transcriptional and mutational
analysis.
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RESULTS AND DISCUSSION
With the goal to better understand the processes of phase variation and rugose colony
formation in V. vulnificus, we chose to compare the whole cell proteomic profiles of strain, YJ016
to that of its isogenic derivative, rugose derivative KG3(R) (Garrison-Schilling, Kaluskar et al.
2014). Whole cell proteins were extracted from mid-log cultures by a combination of the TCA
method and phenolic isolation. Our results indicated that there was a 3 to 9 fold increase in protein
yield when a combination of TCA and phenol was used as opposed to TCA only. 2DGE separation
of proteins on 4-7 pH Immobiline strips and 12.5% polyacrylamide gels (Figure 3.1a, b) and
subsequent analysis of protein spots by PDQuest software identified 28 proteins that were at least
1.5 fold differentially expressed between the O and the R strains with 95 % confidence levels.
However, this approach did not address differences in enzyme activities of the proteins. The results
of the MS analysis of the 28 differentially expressed proteins are listed in Table 3.1 (see Appendix
C, Table C1). Most of the proteins analyzed were downregulated in the R strain as compared to
the O form. Polar flagella proteins, numerous proteins involved in metabolic pathways,
transcription factors, proteases, elongation factors and uncharacterized proteins displayed varied
increases or decreases between phases. Genes involved in metabolic functions such as purine
metabolism, vitamin B5 synthesis, alanine aspartate metabolism, sugar binding proteins and
uncharacterized protein domains showed an increase in the biofilm-proficient R strain. We have
identified novel uncharacterized proteins that may be important for biofilm formation.
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Figure 3.1: 2DGE separation of opaque and rugose V.vulnificus phase variant proteins. (a) Protein
separation was carried out on 4-7 pH Immobiline strips in the first dimension and 12.5 %
polyacrylamide gels in the second dimension. Arrows in the representative portion of the gels
indicate proteins identified by Progenesis software to be differentially expressed between phase
variants. Inset figures show the biofilm-proficient strain KG3(R) and opaque strain YJ016. (b) Gel
sub-sections of protein spots identified by Progenesis software to be differentially expressed in the
opaque (O) and rugose (R) V.vulnificus phase variants YJ016 and KG3(R) respectively.
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Table 3.1: Mass Spectrometric analysis results of proteins identified by PDQuest to be at least 1.5fold differentially expressed with 95 % confidence limits between opaque and rugose phase
variants of V. vulnificus.
Spot # Swissprot Accession #

Description

Exclusively present in Rugose
5403

Q7MIG1

Elongation factor Ts Vibrio vulnificus YJ016 tsf

1616

Q8DD27

Putative elongation factor Tu-like protein Vibrio
vulnificus VV1_1204

1502

No hits

Increased in Rugose
1108

No hits

2510

Q8D6Q8|ADD_VIBVU

Adenosine deaminase Vibrio vulnificus add

3504

Q7MHV3

Pantothenate synthetase Vibrio vulnificus YJ016 panC

7710

Q8D6Q0

Alanine racemase 2 Vibrio vulnificus alr2

1505 P18815

Maltose binding periplasmic protein
Enterobacter aerogenes malE

4206

Q7MMG7

ATP dependent Clp protease proteolytic
subunit Vibrio vulnificus YJ016 clpP

5205

Q7MMT3

UPF0319 protein VV0984 Vibrio vulnificus
YJ016 VV0984

Decreased in Rugose
1503

Q56703|FLAA_VIBPA

Polar flagellin A Vibrio parahaemolyticus flaA

1602

Q56712|FLAC_VIBPA

Polar flagellin C Vibrio parahaemolyticus flaC

2601

Q56702|FLAB_VIBPA

Polar flagellin B/D Vibrio parahaemolyticus flaB

4208

P52626

Putative amino acid ABC transporter binding protein
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(Table 3.1 continued)
Spot # Swissprot Accession #

Description
Vibrio harveyi patH

4805 Q7MHA5|CYSJ_VIBVY Sulfite reductase [NADPH] flavoprotein alphacomponent Vibrio vulnificus YJ016 cysJ
2708

Q7MH72

Argininosuccinate synthase Vibrio vulnificus
YJ016 argG

4509

B5FFK8

6809 Q8DD27

o succinylbenzoate synthase Vibrio fischeri menC
Putative elongation factor Tu-like protein
Vibrio vulnificus VV1 1204

7306 Q7MFN1

Putative hydrolase VVA0289 Vibrio vulnificusYJ016
VVA0289

7510

Q7MMV0

Flagellar P ring protein Vibrio vulnificus YJ016 flgI

5309

Q8D8X2

Ribosomal small subunit pseudouridine synthase A
Vibrio vulnificus rsuA

5604

Q7MPS9

Coenzyme A biosynthesis bifunctional protein CoaBC
Vibrio vulnificus YJ016 coaBC

6808 O64647

Transcription factor TCP9 Arabidopsis thaliana TCP9

7301

Dethiobiotin synthetase Vibrio vulnificus YJ016 bioD

Q7MLU7

1601

No hits

7602

No hits

3706

No hits

5404

No hits
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The results reveal that some putative elongation factors (EFs), were exclusively associated
with the R form while another one was diminished in this form. Similar results have been observed
in Streptococcus mutans where EFs increased from 1.9 to 8.1-fold in biofilms as compared to the
planktonic stage (Svensater, Welin et al. 2001). Since EF-G along with initiation factor 2 (IF2)
have been reported to act as chaperones to protect E. coli cells from stress (Caldas, Laalami et al.
2000), there is a possibility that some EF’s are a part of a response to the stressful conditions,
which are known to induce biofilms in bacteria (O'Toole and Stewart 2005). On the other hand,
some EFs and ribosomal proteins appear to be downregulated in Streptococcus pneumoniae
biofilms since biofilm state is considered to be quiescent (Gilbert, Maira-Litran et al. 2002,
Sanchez, Kumar et al. 2011).
Adenosine deaminase, Ada, an enzyme involved in purine metabolism which catalyzes the
conversion of adenosine to inosine, increased in the R form compared to the O parent. Studies in
Pseudomonas aeruginosa have reported that supplementation of 10 mM adenosine to the medium
reduced rhamnolipid and EPS production, thereby preventing swarming and biofilm formation;
however, the adenosine metabolite, inosine did not inhibit biofilm formation at the same
concentration (Sheng, Pu et al. 2012). This could explain the increase of Ada in the V. vulnificus
R form. In contrast, Actinobacillus pleuropneumoniae microarray analysis data has shown that
tRNA- specific Ada is downregulated in biofilm enhancing media (Labrie, Pelletier-Jacques et al.
2010). Also in Shewanella oneidensis, 2DGE data has identified a downregulation of Ada in the
biofilm form compared to the planktonic form (De Vriendt, Theunissen et al. 2005). The
contradicting phenomena seen in P. aeruginosa, A. pleuropneumoniae and S. oneidensis suggests
that the role of Ada in biofilm formation may differ amongst bacterial spp. Our proteomic data
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seems to support the inhibitory effect of adenosine on V. vulnificus biofilms but this hypothesis
needs further experimental validation.
Pantothenate synthase, PanC, an enzyme involved in vitamin B5 synthesis was expressed
at higher levels in the R as compared to the O form. Vitamin B5 is required for synthesis and
metabolism of proteins, fats and carbohydrates. It is also required for coenzyme A (CoA) synthesis,
which on acetylation forms acetyl CoA. Microarray experiments in Escherichia coli have reported
that carbon sources, which can be metabolized into acetyl CoA, acetyl phosphate and acetate,
support biofilm formation. Acetate metabolism in E.coli is a sensory relay of the environmental
conditions towards biofilm formation (Pruss, Verma et al. 2010), and E.coli cells altered in their
ability to metabolize acetyl phosphate cannot construct normal biofilms (Wolfe, Chang et al.
2003). But the direct role of CoA in biofilms is not known (Pruss, Verma et al. 2010). Our results
also indicate a decrease in the coenzyme A biosynthesis proteins, CoaBC in the R form. These
results imply that vitamin B5 (pantothenate) may play a role in V. vulnificus biofilm formation but
perhaps not via coenzyme A synthesis.
One of the proteins increased in the R phenotype was identified by MS and Swiss Prot
analysis to be MalE (maltose-binding periplasmic protein). RNA dot blots using malE gene as a
probe exhibited a 2.5 fold increase in malE transcript in KG3(R) as compared to YJ016 (Figure
3.2). malE (VVA0397) is situated immediately upstream of the brp gene cluster, which is required
for V. vulnificus biofilm formation, as genes in this cluster are involved in EPS biosynthesis and
transport (Grau, Henk et al. 2008, Guo and Rowe-Magnus 2010). Comparative microarray analysis
of biofilm and planktonic E.coli cells has reported malE to be upregulated in biofilms of that
organism (Schembri, Kjaergaard et al. 2003). Additionally, genes involved in maltose transport
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and metabolism have been reported to be increased in E. coli biofilms (Beloin, Valle et al. 2004).
Given this, we wanted to determine if MalE had a role in V. vulnificus rugosity and consequently
biofilm formation.

Figure 3.2: RNA dot blot hybridization with radiolabeled malE (VVA0397) probe showing 2.5fold increased transcription of malE in rugose strain KG3(R) as compared to the opaque variant
YJ016. gDNA at various concentrations was used as a positive control.

To determine the role of MalE in V. vulnificus rugose colony and biofilm formation, we
created a polar insertional mutant in malE gene in strain KG3(R) by deleting the functional
domains and inserting a kanamycin resistant cassette at the site of deletion (Figure 3.3).
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Figure 3.3: PCR verification of malE (VVA0397) mutants obtained by deletion of functional
domains and insertion of kanamycin cassette. Lanes 1, 15:1 kb+ DNA ladder; 2-11, 13: putative
transconjugants, 12: negative control, 14: KG3(R) gDNA.

The mutant isolates, ZK-32, ZK-45 and ZK-49 retained the rugose colony phenotype of
the parental strain (Figure 3.4). This result suggests that malE is not involved in the R phenotype
or there could be a different gene somehow compensating for the loss of function in malE.
There does exist another potential maltose binding periplasmic protein (VVA0056 gene
product) in the genome of YJ016, which is 56 % identical in amino acid composition to MalE
(VVA0397 gene product). It would be worthwhile to study the effect of the double mutant on
rugosity.
While it is known that biofilm formation in Enterococcus faecalis and S. mutans is induced
by the presence of maltose (Creti, Koch et al. 2006, Klein, DeBaz et al. 2010), it has been
demonstrated in V. vulnificus and Vibrio cholerae that maltose inhibits biofilm formation (Ali,
Morris et al. 2005, Kim, Park et al. 2009).
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KG3(R)

-

ZK-32 (malE )

-

ZK-45 (malE )

-

ZK-49 (malE )

Figure 3.4: malE (VVA0397) is not involved in the rugose phenotype of V. vulnificus. Mutants in
malE were created by deleting the functional domains and inserting a kanamycin resistant marker
in the open reading frame (ORF) of VVA0397. All the three malE mutant isolates (ZK-32, ZK-45
and ZK-49) constructed retained the rugose phenotype of the parent KG3(R) strain.

It is possible that other products transported through the malEFG operon may act as a signal
for biofilm formation. In E. coli, the presence of maltotriose in the medium, which is also
transported by the malEFG products, results in increased biofilm formation (Mugabi, Sandgren et
al. 2012). It is also possible that byproducts of maltose or maltodextrin hydrolysis such as glucose
may serve as a structural component of the EPS matrix. The EPS and CPSA polysaccharides,
which are responsible for biofilm and pellicle formation in V. cholerae and Vibrio
parahaemolyticus, respectively, are known to be composed of glucose and various other sugars
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(Yildiz and Schoolnik 1999, Enos-Berlage and McCarter 2000, Enos-Berlage, Guvener et al. 2005,
Yildiz, Fong et al. 2014). Since the EPS composition of V. vulnificus has not yet been clearly
determined, it would be worthwhile to know if maltose or its breakdown product, glucose, acts as
a building block of the EPS matrix. In S. mutans, though maltose has not directly been shown to
be a part of the biofilm matrix, maltose/ maltotriose transport genes are transcriptionally
upregulated at various stages in biofilm development in media containing a combination of starch
and sucrose compared to sucrose only (Klein, DeBaz et al. 2010). In E.coli, maltose gets converted
to acetyl coA, accumulation of which results in increased biofilm formation (Mugabi, Sandgren et
al. 2012).
Alanine racemase, Alr2, which is involved in alanine and aspartate metabolism, by
catalyzing the racemization of L-alanine to D-alanine, was increased in the R form compared to
the O. Our result is consistent with a report in which D- alanine promoted biofilm formation in
Bacillus subtilis, P. aeruginosa and Staphylococcus aureus, whereas the other D- amino acids
promoted biofilm disassembly (Kolodkin-Gal, Romero et al. 2010) due to their toxic effects on
protein synthesis (Leiman, May et al. 2013). Furthermore, D-alanine esters of lipoteichoic acids
are known to promote biofilm formation in E. faecalis (Fabretti, Theilacker et al. 2006).
Expression of an ATP-dependent proteolytic subunit of ClpP was also induced in the R
form. Clp (caesinolytic proteases) are serine proteases, which, in S. aureus, have been shown to
be required for stress tolerance and biofilm formation (Frees, Chastanet et al. 2004). ClpP proteins
are also enhanced in Campylobacter jejuni biofilms (Kalmokoff, Lanthier et al. 2006). Mutations
in ClpP protease genes in Pseudomonas fluorescens and S. mutans inhibited biofilm formation
(O'Toole and Kolter 1998, Lemos and Burne 2002).
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Our study also identified spot 5205, (i.e. the gene product of VV0984), which is an
uncharacterized protein, to be induced in the R phenotype. This is a 245 amino acid hypothetical
protein, harboring DUF 2057 domain, which is present in prokaryotes but its function is yet
unknown. Further studies characterizing the function of this protein and establishing what role it
plays in biofilm formation would be very interesting.
Polar flagellar basal body proteins FlaA, FlaB/D and FlaC and flagellar P ring protein, FlgI
were downregulated in the R form compared to the O form. Reduction in motility by other R V.
vulnificus strains compared to the O and T forms has been previously observed in 0.3 % agar but,
interestingly, the single polar flagellum was retained and cells were able to swim actively in
phosphate buffered saline (Grau, Henk et al. 2005). Biofilm formation begins with bacteria
actively swimming and attaching to a surface. After the initial attachment, microcolony and 3Darchitecture formation begins due to the growth and movement of the attached bacteria. In V.
cholerae, flagellar mutants showed reduced attachment to substrate but they retained the ability to
form vps-dependent biofilms if sufficient time was provided (Yildiz and Visick 2009). In contrast,
flagella mutants in Listeria monocytogenes and E. coli were defective in biofilm formation as
flagella are required in the initial attachment step and during later parts of developments of biofilm
architecture in those species (Pratt and Kolter 1998, Lemon, Higgins et al. 2007). In P. aeruginosa,
flagella are not required for the initial attachment step but mutations in flagellar genes can produce
biofilms with different structures by affecting biofilm development (Klausen, Heydorn et al. 2003).
These different roles of flagella do underline the diversity of mechanisms used by different bacteria
spp. in biofilm formation (Guttenplan and Kearns 2013).
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A putative amino acid transport ABC binding protein, PatH was downregulated in the R
form which is consistent with reports of reduction in ABC transporters in the rugose V. cholerae
strains (Yildiz, Liu et al. 2004). Arginosuccinate synthase, ArgG, is the penultimate enzyme in
arginine synthesis, catalysing arginosuccinate formation from citrulline and aspartate. Our data
showed that ArgG is reduced in the R form. Also, ArgG was reduced in biofilms as compared to
planktonic cells in Desulfovibrio vulgaris (Clark, He et al. 2012).
Expression of sulfite reductase, CysJ was reduced in R forms as compared to the O form.
Sulfite reductase catalyzes the formation of hydrogen sulfide from sulfite and is involved in
sulphur assimilation and selenocysteine metabolism. Biofilms formed by wild type E.coli cells in
LB were similar to a cysJ mutant, which implies that cysJ does not contribute to E.coli biofilm
formation in that medium (Domka, Lee et al. 2007).
Succinylbenzoate synthase, MenC, produces o-succinylbenzoic acid, which is the first
intermediate in the vitamin K2 (menaquinone) biosynthetic pathway. Menaquinone plays a role as
an electron carrier during respiration, but it is also a signal for communicating redox status to twocomponent regulatory systems (Georgellis, Kwon et al. 2001). In E.coli, menC was identified as
being important in biofilms (Junker, Peters et al. 2006).
VVA0289 a hydrolase, harboring the histidinol phosphatase domain, was reduced in the R
form as compared to the O form. Microarray analysis data in E.coli has shown that the hisB gene,
encoding a bifunctional imidazole glycerol phosphate dehydratase/ histidinol phosphatase was
induced 1.5 fold in biofilms subjected to 5-flurouracil (5-FU) (Attila, 2009). However, this study
also found that biofilm formation in the hisB mutant was increased compared to the wild type
strain in the presence of 5-FU.
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Our data also demonstrated that ribosomal small subunit pseudouridine synthase A was
downregulated in the R form compared to the O. Pseudouridine synthases are the enzymes
responsible for posttranscriptional modification of cellular RNAs by catalyzing the site-specific
isomerization of uridine residues that are already part of an RNA chain (Hamma and FerreD'Amare 2006). In P. aeruginosa, it has been reported that uracil-related mutations abolished
biofilm formation (Ueda, Attila et al. 2009). In Leptospirillium Group B and E.coli, pseudouridine
synthase B and C, respectively, increased in the initial stages of biofilm (Ito, Taniuchi et al. 2009,
Mueller, Dill et al. 2011). Finally, our study demonstrated that dethiobiotin synthase, BioD, an
enzyme that synthesizes dethiobiotin and is involved in biotin metabolism, was decreased in the R
form compared to the O. In contrast, in E. coli, the bioD gene, is upregulated in the early stages of
biofilm formation (Ito, Taniuchi et al. 2009). On whole, the differences observed in our data and
some of the previously reported studies underline the diverse mechanisms and strategies utilized
by the bacterial world to promote biofilm formation.
MATERIALS AND METHODS
Strains and growth conditions: V. vulnificus strain, YJ016 - an opaque clinical isolate
from Taiwan (Chen, Wu et al. 2003) and its spontaneous rugose derivative, KG3(R) (GarrisonSchilling, Kaluskar et al. 2014) were stored at -70 °C in heart infusion broth (Difco) supplemented
with a total of 2 % NaCl (HI) and 15 % glycerol. V. vulnificus strains were streaked on HI agar
supplemented with 18g/L non granulated agar (Difco) and incubated at 30 °C overnight (ON) for
16-24 hours for single colony isolation. Broth cultures were propagated in HI broth at 30 °C and
200 rpm ON. E. coli strains were stored at -70 °C in Luria-Bertani (LB) broth (Difco)
supplemented with 20 % glycerol. These were streaked on LB agar supplemented with 15 g/L
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granulated agar (Difco) and incubated at 37 °C ON for single colony isolation. Broth cultures were
propagated in LB broth at 37 °C and 250 rpm ON. Antibiotics (Sigma) were used as follows when
needed: 50µg/ml ampicillin and 150µg/ml kanamycin for V. vulnificus and 50µg/ml ampicillin and
50µg/ml kanamycin for E. coli. Strains and plasmids used in this study are listed in Tables 3.2 and
3.3 respectively.

Table 3.2: Strains used in this study
Strain

Genotype/Description

Reference

E.coli
SY327λpir ∆(lac pro) argE(Am) rif malA

(Miller and Mekalanos 1988)

recA56 λpir
S17.1λpir

thi pro hsdR hdsM+ recA

(Simon, Priefer et al. 1983)

RP4-2-Tc::Mu-Km-Tn7 λpir
V. vulnificus
YJ016

encapsulated, opaque clinical strain, Taiwan

KG3(R)

isogenic rugose phase variant

(Chen, Wu et al. 2003)

(Garrison-Schilling, Kaluskar 2014)

obtained from YJ016
ZK-32

polar mutant of malE in KG3(R), KanR

This study

ZK-45

polar mutant of malE in KG3(R), KanR

This study

ZK-49

polar mutant of malE in KG3(R), KanR

This study
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Table 3.3: Plasmids used in this study
Plasmid

Description

Source/Reference

pSP72

cloning vector, AmpR

pGP704sacB

suicide vector, AmpR

pVV67

malE fragment cloned in pSP72, AmpR

This study

pVV71

nonpolar KanR cassette inserted in the malE

This study

Promega
(Lim, Beyhan et al. 2006)

fragment of pVV67, AmpR, KanR
pVV74

malE-KanR cassette from pVV71 cloned into

This study

pGP704sacB, AmpR, KanR

Protein extraction: All chemicals used were of analytical grade. Tricarboxylic acid
(Sivaraman, Kumar et al. 1997) sodium dodecyl sulfate (SDS), iodoacetamide (IAA) were
purchased from Sigma. Methanol, ammonium acetate, acetone, glycerol, sodium phosphate and
potassium phosphate were purchased from Mallinckrodt (St. Louis, Missouri). Immobiline Dry
Strip (pH 4.0 to 7.0, nonlinear 18 cm) and dithiothreitol (DTT) were purchased from GE
Healthcare Biosciences. Tris, bromophenol blue, ethylenediaminetetra acetic acid (EDTA),
phenol, beta mercaptoethanol (β-ME), urea, 3-([3-Cholamidopropyl]-dimethyl-ammonio)-1propane-sulfonate) (CHAPS), ammonium persulfate (APS) and N,N,N9, N9,-tetramethylethylenediamine (TEMED) were purchased from Amresco. Surcose and Pefabloc were purchased
from Matheson, Coleman and Bell and Roche, respectively.
Proteins were extracted from at least 3 different cultures started from 3 independent single
colonies for each strain. Broth cultures were started by inoculating a single isolated colony of the
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correct morphology into 3 ml HI broth. This culture was termed the ON. The ONs were then
subcultured 1:100 in fresh HI medium and grown until mid-exponential phase (OD600 between 0.4
and 0.6). Upon reaching desired OD600, broth cultures were again subcultured 1:100 into 250 ml
HI broth and cells were harvested at mid-exponential phase by centrifugation at 4,332 x g for 10
min at room temperature (RT). Cells were washed by centrifugation at 4,332 x g for 5 min twice
in 5ml 1 X PBS buffer and pellets were then resuspended in 5 ml lysis buffer (10 mM Tris HCl
pH 8.0, 5 mM EDTA, 1mM Pefabloc). Cell pellets were disrupted by sonication (3 x 10 pulses at
setting 3). Mixtures were then centrifuged at 4,472 x g for 10 min at 4 °C. In case a cell pellet was
seen, the mixture was sonicated again to lyse all the cells. Proteins in the supernatant were
precipitated with TCA (final concentration of 10 %) and incubated on ice for 30 min. Precipitated
proteins were collected by centrifuging at 14,881 x g for 15 min. To the precipitate, 2.5 ml/g of
Tris-saturated phenol (pH 8.0) and 2.5 ml of SDS extraction buffer (2 % SDS, 30 % sucrose, 0.5
% βME) were added. Samples were mixed by vortexing for 1 min and then placed on ice for 1
min. This process was repeated for a total of 15 times. Mixtures were then centrifuged at 14,881 x
g for 10 min at 4 ºC. To the upper phenol phase, 20 ml of 80 % methanol containing 0.1 M
ammonium acetate (Hurkman and Tanaka 1986) was added and stored at -30 ºC overnight . The
mixture was then centrifuged at 14,881 x g for 30 min (4 ºC). Supernatants were then discarded
and pellets were washed with 10 mL 100 % methanol by chopping the pellets and vortexing for 3
min. Mixtures were then spun at 14,881 x g for 20 min at 4 ºC. Supernatants were discarded and
pellets were washed with 80 % acetone by chopping and vortexing for 3 min. Mixtures were
centrifuged at 14,881 x g for 20 min at 4 °C and the supernatants were discarded. Protein pellets
were then allowed to air dry for 10-15 min and stored at -30 ºC.
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Two dimensional gel electrophoresis (2DGE): A small amount of protein pellet (20-50
mg) was resuspended in 100 µl of lysis buffer (8M Urea, 4 % w/v CHAPS, 40 mM DTT, 2 %
v/v 4-7 IPG buffer in deionized water) and allowed to sit at RT for at least 30 min before it was
disrupted to dissolve. Protein concentration was measured at OD595 by the Bradford method using
Bio-Rad Protein Assay Dye. The mixture was then spun in a table top centrifuge at 2410 x g for
10 min at RT to remove the undissolved proteins. Protein (150 µg) dissolved in lysis buffer was
added to IPG Strip rehydration buffer (Urea 8 M, Bromophenol blue trace, 2 % (w/v) CHAPS, 0.5
% 4-7 IPG buffer, 20 mM DTT in deionized water) such that the total volume was 340 µl for an
18 cm strip. Strip rehydration was carried out by placing the above 340 µl solution in each lane of
a rehydration tray. The gel side of the 4-7 IPG strips was placed face down to directly contact the
solution to avoid bubbles. The strips were covered with 2-3 ml Dry Strip cover fluid to prevent
drying. Rehydration was carried out for at least 12 hrs at RT. Isoelectrofocussing (IEF) was carried
out at 20 °C with 500 V for 1.5 hrs, and then with 1000 V for 1.5 hrs, and finally at 8000 V for 5
hrs. After IEF was completed, strips were equilibrated as follows: (a) 40 min of slow shaking at
RT in SDS equilibration buffer containing DTT (50 mM Tris HCl, pH 8.8, 6 M urea, 30 % (v/v)
glycerol, 2 % (w/v) SDS, 1 % bromophenol blue, 1 % DTT in deionized water) (b) 50 min of slow
shaking at RT in SDS equilibration buffer containing IAA (50 mM Tris HCl, pH 8.8, 6 M Urea,
30 % (v/v) glycerol, 2 % (w/v) SDS, 1 % Bromophenol blue, 2.5 % IAA, in deionized water).
Second dimension electrophoresis was carried out at 18 °C in 12.5 % acrylamide gels for 1 hr 40
V and then 15 hrs at 120V (Laemmli 1970). Analytical gels were stained with Dodeca silver stain
kit (Bio-Rad), scanned with UMAX PowerLook II scanner (UMAX data systems, Taiwan), and
analyzed by Progenesis SameSpots software (Nonlinear Dynamics, Durham, NC). Preparative gels
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were stained with SYPRO Ruby (Bio-Rad) according to the manufacturer instructions, and then
scanned and analyzed by PDQuest software (Bio-Rad) at the Pennington Biomedical Research
Center.
Spot excision and in-gel tryptic digestion: Briefly, 2-mm gel plugs were excised
automatically using ProteomeWorks spot cutter (Bio-Rad) and deposited in a 96-well plate. In-gel
tryptic digestion was performed using an automated robotic workstation (MassPrep, Waters
Corp.). Gel plugs were washed with NH4HCO3 and CH3CN followed by reduction and alkylation
using 10 mM DTT and 55 mM IAA, respectively. Proteins were cleaved by sequencing grade
trypsin (150 ng/gel plug) at 37 °C ON. The peptide fragments were extracted with 2 % CH3CN
and 1 % HCOOH in water and directly analyzed using liquid chromatography (LC) – tandem mass
spectrometry (MS/MS) (Zvonic, Lefevre et al. 2007), at the Pennington Biomedical Research
Center, LA.
Protein identification using LC-MS/MS: The peptides from each digested spot were
separated and analyzed using a capillary LC system coupled on-line with a nanospray quadrupole
time-of-flight (Q-TOF) MS (Waters, Corp.) as described previously (Zvonic, Lefevre et al. 2007).
Tandem mass spectra were analyzed using the ProteinLynx Global Server (PLGS) 2.2.5 software
(Waters, Corp.) against the Swiss Prot database. The database search settings included one missed
tryptic cleavage and fixed carbamidomethylation of cysteine residues (Zvonic, Lefevre et al.
2007). In some cases, MS/MS data was also identified using MASCOT search engine (Perkins,
Pappin et al. 1999). De novo sequencing from MS/MS data was also performed using Peaks
software (Ma, 2003).
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Protein sequence analysis for MalE: Proteins identified by Swiss Prot were BLASTed
against the genome sequences of V. vulnificus in the National Center for Biotechnology
Information (NCBI) database using Basic Local Alignment Search Tool (BLAST) (Altschul,
Madden et al. 1997).
Genetic manipulation techniques: Standard DNA techniques were carried out using
molecular protocols (Sambrook, Fritsch et al. 1989). Restriction enzymes, calf intestinal alkaline
phosphatase (CIP), T4 DNA polymerase and Klenow polymerase were obtained from New
England BioLabs. Pfu polymerase, Amplitaq and primers were obtained from Stratagene, Applied
Biosystems and Sigma Genosys, respectively.
Generation of malE insertion mutant: Polymerase chain reaction (PCR) was performed
to amplify a 1853 bp fragment with XbaI ends (underlined) using YJ016 gDNA as template and
primers MalEF (5′-AAAAATCTAGAACTCGCCTACATCCTCCTAC-3′) and MalER (5′AAAAATCTAGAAAATCATCCCGGCAATACCC-3′). Each 50-µl PCR reaction contained 5 µl
of 10X buffer, 4 µl of 10 mM dNTP mixture (each at a 2.5 mM concentration), 1 µl each of the 20
µM primers, 1 µl of 2.5 U/µl Pfu polymerase, 100 ng YJ016 gDNA and nuclease free water to
make up volume. The PCR cycle conditions were as follows: 95 °C for 2 min, followed by 30
cycles of 95 °C for 45 sec, 55 °C for 45 sec, and 72 °C for 1.5 min. A final extension step consisted
of 72 °C for 10 min and final hold was at 4 °C. PCR reactions were analyzed by agarose gel
electrophoresis. Cleaned products were cloned into the XbaI site of pSP72 (Promega) to create
pVV67. The insert sequence of pVV67 was sequenced using BigDye v3.1 (Applied Biosystems)
and primers MalEF, MalER, MalESeqF (5′-GCGCTGCAAGATAAATTCCC-3′) and MalESeqR
(5′-GTTTGACGACCATCCACTAC-3′) as previously described (Garrison-Schilling, Grau et al.
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2011). pVV67 was then double digested with AfeI and NsiI to delete the functional domain of the
malE gene. An 840-bp, blunt-ended, nonpolar kanamycin-resistant cassette, generated by SmaI
digestion, (Menard, Sansonetti et al. 1993) was then cloned into the AfeI, NsiI sites after they were
made blunt ended by using T4 DNA polymerase and nucleotides to remove 3′ overhangs, in order
to create pVV71. The ~ 1.6-kb XbaI fragment of pVV71 was then cloned into the XbaI site of
pGP704sacB (Lim, Beyhan et al. 2007) to create pVV74, which was maintained in E. coli strain
SY327λpir and later transformed into E. coli S17.1λpir. Matings were carried out between KG3(R)
and S17.1λpir on membrane filters. Ampicillin-sensitive, kanamycin-resistant transconjugants,
which had undergone double homologous recombination, were selected. Mutants were confirmed
by polymerase chain reaction (Grau, Henk et al. 2008) using Amplitaq and primers MalEF and
MalER.
RNA dot blot analysis: Total RNA extraction and dot blot hybridization were conducted
as previously described (Grau, Henk et al. 2008), with the only modification being that 5 µg, 500
ng and 50 ng RNA samples were used for each strain. PCR reactions were performed with primers
malE-For

(5′-GGGCAACATTGAGAAGTCTG-3′)

and

malE-Rev

(5′-

GTTTGACGACCATCCACTAC-3′) and strain YJ016 gDNA to generate a 372-bp probe for the
hybridization reactions. The PCR-amplified, VVA0397 (malE) probe was radiolabeled using the
NEBlot random priming kit (New England BioLabs) and [α-32 P] dATP (3,000 Ci/mmol).
Approximately 108 cpm of radiolabeled probe was used for hybridization as described earlier
(Grau, Henk et al. 2008). Briefly, dot blots were exposed to a phosphor screen for 2 hrs at RT. The
screen was then scanned with a Typhoon scanner (GE Healthcare, Piscataway, NJ). Image
quantification was performed using ImageQuant volume quantitation (GE Healthcare). Induction
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levels were calculated by dividing the sum of the pixel values above the background level for each
KG3(R) spot by the average sum of the pixel values for the YJ016 spots.
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CHAPTER 4
DISTRIBUTION STUDIES OF THE wcr (brp) GENE CLUSTER IN V. VULNIFICUS
INTRODUCTION
Vibrio vulnificus (V. vulnificus), is a bacterium inhabiting estuarine warm waters around
the world. In these natural habitats, it is found at high concentrations in the guts of filter feeding
mollusks such as shrimp, lobsters and oysters, in the sediments and also in the water column. Being
a human pathogen, it is known to have the highest mortality rate among seafood pathogens (Gulig,
Bourdage et al. 2005, Oliver 2013). Pathogenesis is directly correlated to the presence of capsular
polysaccharide (CPS) which aids in bacterial defense from the human immune system (Linkous
and Oliver 1999, Simpson, White et al. 1987, Strom and Paranjpye 2000, Yoshida, Ogawa et al.
1985). Diseases in humans are caused by consumption of raw seafood, especially oysters and also
by contact of skin abrasions to seawater or seafood drippings. Virulent encapsulated opaque (O)
colony forming strains undergo capsular phase variation, which results in avirulent, translucent
(T) colony forming strains that are acapsular or greatly reduced for capsule production (Yoshida,
Ogawa et al. 1985, Simpson, White et al. 1987, Wright, Powell et al. 2001). The opaque and the
translucent strains can undergo further phase variation which results in production of a separate
exopolysaccharide (EPS) and rugose (R) colonies. The R phenotype can form abundant biofilms
under certain laboratory conditions. (Grau, Henk et al. 2005, Grau, Henk et al. 2008, GarrisonSchilling, Grau et al. 2011).
Rather than living as single solitary entities, bacteria in the environment are known to exist
in biofilm communities. The biofilm matrix, which is typically composed polysaccharides,
proteins and extracellular DNA, confers advantages like nutrient sequestration, protection from
grazing and combat various environmental stresses (Flemming and Wingender 2010). When in
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association with mollusks like oysters, V. vulnificus is thought to exist in its opaque encapsulated
form but when present in the water column or in the sediments, it is thought to be present in the
rugose form (Srivastava, Tucker et al. 2009). Consequently, biofilm formation, capsule formation
and thereby polysaccharide production seem to be processes of prime importance in V. vulnificus.
A number of loci involved in CPS and EPS expression have been identified though most
may not be highly conserved among V. vulnificus strains based on the genomic analysis to date.
One known exception to this is the group I CPS operon, which is conserved in various V. vulnificus
strains (Wright, Powell et al. 2001), including the sequenced strains (Chen, Wu et al. 2003, Park,
Cho et al. 2011). It is at this locus where deletions of the wzb gene, caused by homologous
recombination between flanking direct repeats, resulted in strains that remained locked in the
translucent phase (Chatzidaki-Livanis, Jones et al. 2006, Garrison-Schilling, Grau et al. 2011).
Another potentially conserved locus is the nine-gene brp (formerly wcr) cluster, which was
expressed at higher levels in the R forms compared to the O and T (Grau, Henk et al. 2008, Guo
and Rowe-Magnus 2010). This locus encodes determinants for EPS expression (and thus efficient
biofilm formation) and is present in all the three sequenced strains of V. vulnificus as well as the
clinical isolate 1003(O). Since many of the brp genes are required for rugosity and efficient
biofilm formation, we also hypothesized that this locus likely provides a survival advantage in the
environment, and, as such, it would be predicted to be well-conserved among strains of this
species. This possibility was tested by screening for the presence of the brp cluster in a number
of clinical and environmental strains. Here, we have analyzed the distribution of this cluster among
V. vulnificus strains by using a combination of PCR-based linkage analysis and Southern blotting
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and have found that the brp genes are widespread and seem to be evolutionarily conserved in this
species (Garrison-Schilling, Kaluskar, 2014).
RESULTS AND DISCUSSION
The brp locus is well conserved in V. vulnificus. Linkage PCR was performed as
previously described (Grau, Henk et al. 2008) to determine that 32 of the 33 V. vulnificus strains
in our laboratory collection contained the brp locus with no insertions or deletions (Table 4.1). As
a comparison, all 32 strains also showed evidence of the well-conserved Group I CPS operon
(Wright, Powell et al. 2001, Chatzidaki-Livanis, Jones et al. 2006) based on the presence of an
intact wzb gene. The lone exception was the environmental isolate MLT198, which lacked both
the wzb gene and the brp cluster (Table 4.1), and was therefore unable to form any translucent or
rugose colonies, respectively (Table 4.2). To further characterize the brp genes in the 32 strains,
Southern blot hybridization was performed, which showed that 18 of the 32 brp+ strains were of a
single 10.5 kb PstI restriction fragment length polymorphism (RFLP) profile (Table 4.1). The
exact profile of the other 14 could not be determined from the available data. An additional nine
recently-isolated environmental V. vulnificus strains were also analyzed for the brp cluster and all
were found to be brp+ by linkage PCR analysis (Table 4.1). Interestingly, Southern blot
hybridization profiles of these strains revealed two distinct PstI RFLP profiles: a 10.5 kb band
(observed in 18 of the originally tested strains) or a 2.7 kb band, which was not present in the
original 32 strains (Table 4.1, Figure 4.1). The presence of all brp genes as determined by PCR
analysis coupled with the occurrence of the 2.7 kb RFLP band in 6 out of the 9 newly isolated
strains tested indicated that there could have been base changes in these strains which resulted in
a different sized PstI fragment upon Southern blot analysis.
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Table 4.1: V. vulnificus strains were analyzed by PCR and Southern hybridization for the brp
cluster and by PCR for the wzb gene.
Presence of brp
cluster
Linkage
Strain

PCR1

Presence
of wzb

Southern2

PCR1

(kb)

Lab strains
1001

+

10.5

+

1003(O)

+

10.5

+

1004

+

10.5

+

1005

+

10.5

+

1007

+

-

+

1009

+

-

+

1014

+

-

+

1456(O)

+

10.5

+

1456(T)

+

-

+

1657(O)

+

-

+

1657(T)

+

-

+

95-10-15

+

10.5

+

96-7-155

+

-

+

ABZ1(R)

+

-

+

ABZ1(T)

+

-

+

ATCC27562

+

10.5

+

AZ(T)

+

-

+

BG(R)

+

-

+

C7184

+

-

+
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(Table 4.1 continued)
Presence of brp
cluster
Linkage
Strain

PCR1

Presence
of wzb

Southern2

PCR1

(kb)

CMCP6

+

-

+

CPClam2

+

10.5

+

CPMussel10

+

-

+

CPSed5

+

10.5

+

F8Oyster11(O)

+

10.5

+

F8Oyster11(T)

+

10.5

+

KG3(R)

+

10.5

+

KG4(T)

+

10.5

+

MLT124

+

10.5

+

MLT136(O)

+

10.5

+

MLT136(T)

+

10.5

+

MLT141

+

10.5

+

MLT198

-

-

-

YJ016

+

10.5

+

132a1

+

10.5

ND

132z2

+

2.7

ND

212b6

+

2.7

ND

212f15

+

2.7

ND

212s7

+

2.7

ND

342e9

+

10.5

ND

Newly isolated strains
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(Table 4.1 continued)
Presence of brp
cluster
Linkage
Strain

PCR1

Presence
of wzb

Southern2

PCR1

(kb)

342s6

+

2.7

ND

NOLA18

+

-

ND

212f18

+

2.7

ND

1

+ or – indicates the presence or absence, respectively, of all genes in the brp cluster (first column
of data) or the wzb gene (third column of data).

2

Indicates the size of the band hybridized to a radiolabeled probe specific for brpC (lab strains) or
brpI (newly isolated strains). A ҅–҆ indicates that either no bands were present or that band size
could not be determined.
ND, not determined.

Table 4.2: Strain MLT198, which lacks both the wcr (brp) genes and the wzb gene, is unable to
phase switch to either the rugose or the opaque phenotype. Phenotypic switching assays were
performed on MLT198 and BGT1 in HI broth. Data presented are the means and standard
deviations of at least 3 independent trials.

Parent strain

MLT198
BGT1

% of total colonies with the following phenotypes (Avg. ± SD)a
O

R

T

0.00

0.00

99.90 ± 0.10b

16.90±18.90

15.20 ± 18.60

63.90±19.30

a

Total percentage of colonies does not equal to 100 because some colonies had an intermediate
phenotype.
b

Total of 18,863 colonies counted.
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As previously seen for strains with the 10.5 kb RFLP profile, strains with the 2.7 kb profile
also retained the ability to switch to the rugose phenotype (Figure 4.2) and they produced pellicles
in culture (data not shown).
Overall, the presence of the brp cluster in 41 out of 42 strains provides direct evidence that
these genes are a widespread, evolutionarily conserved locus that is important for the survival of
this organism.

1

2

3

4

5

6

7

10.5 kb

2.7 kb

Figure 4.1: Southern hybridization showing 10.5 and 2.7 kb RFLP profiles of different V.vulnificus
strains probed with wcrI. Lanes 1 through 7: 132a1, 132z2, 212b6, 212f15, 212s7, 342e9, 342s6.
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120.0%
passage 5

ON

% colonies

100.0%
80.0%
60.0%
40.0%
20.0%
0.0%
O

T

R

O

T

R

colony phenotype
Figure 4.2: Switching assays were performed on strain 212f15 in HI medium. Data presented are
the means and standard deviations of at least 3 independent trials.
MATERIALS AND METHODS
Bacterial strains & growth conditions: All V. vulnificus strains used in this study are
listed in Table 4.3 and were grown in heart infusion broth (HI) (Difco) supplemented to 2% NaCl
and on HI agar plates containing 18 g/l of agar (Difco). Broth cultures were incubated at 30C and
200 rpm overnight (ON) for 16-24 hours; plates were incubated ON for 16-24h at 30C. To confirm
their identity, recent isolates of V. vulnificus were first grown on CHROMagar Vibrio
(CHROMagar) and TCBS agar (Difco), followed by 16S rRNA gene sequencing as described
(Grau, Henk et al. 2008).
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Table 4.3: V. vulnificus strains used in this study
Strain

Description

Source

10011,2

blood isolate, opaque

(Martin and Siebeling 1991)

1003(O) 1,2

formerly 1003; wound isolate from Louisiana,

(Martin and Siebeling 1991)

opaque
10041,2

stool isolate, opaque

(Martin and Siebeling 1991)

10051,2

blood isolate, opaque

(Martin and Siebeling 1991)

10071,2

blood isolate, opaque

(Martin and Siebeling 1991)

10091,2

blood isolate, opaque

(Martin and Siebeling 1991)

10141,2

blood isolate, opaque

(Martin and Siebeling 1991)

1456(O) 1,2

unknown origin, opaque

Lab collection

1456(T) 1,2

spontaneous translucent variant of 1456(O)

Lab collection

1657(O) 1,2

unknown origin, opaque

Lab collection

1657(T) 1,2

spontaneous translucent variant of 1657(O)

Lab collection

95-10-151,2

unknown origin, opaque

Lab collection

96-7-1551,2

eel isolate, opaque

Lab collection

ABZ1(R) 1,2

spontaneous rugose isolate of ABZ1(T)

ABZ1(T) 1,2

transposon mutant of 1003(O)

(Grau, Henk et al. 2005)
(Zuppardo and Siebeling 1998)

(wcvA::mini-Tn10), translucent
AZ(T) 1,2

spontaneous translucent isolate of 1003(O)

BG(R) 1,2

spontaneous rugose isolate of 1003(O)

C71841,2

clinical isolate, opaque

(Zakaria-Meehan, Massad et al. 1988)

CMCP61,2

clinical isolate, opaque

(Kim, Lee et al. 2003)

CPClam21,2

oyster isolate, opaque

Lab collection

CPMussel101,2 oyster isolate, opaque

Lab collection

CPSed51,2

sediment isolate, opaque

(Zuppardo and Siebeling 1998)
(Grau, Henk et al. 2005)

(Garrison-Schilling, Grau et al. 2011)
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(Table 4.3 continued)
Strain

Description

Source

F8Oyster11(O) 1,2 oyster isolate, opaque

Lab collection

F8Oyster11(T)1,2 spontaneous translucent variant of F8Oyster11(O)

Lab collection

KG3(R)1,2

spontaneous rugose isolate of YJ016

(Garrison-Schilling dissertation,
LSU, 2011)

KG4(T) 1,2

spontaneous translucent isolate of YJ016

(Garrison-Schilling dissertation,
LSU, 2011)

MLT1241,2

oyster isolate, opaque

MLT136(O)1,2

formerly MLT136, oyster isolate, opaque (Garrison-Schilling, Grau et al. 2011)

MLT136(T)1,2

spontaneous translucent isolate of MLT136(O)

Lab collection

MLT1411,2

oyster isolate, opaque

Lab collection

MLT1981,2

sediment isolate, translucent

Lab collection

YJ0161,2

clinical isolate from Taiwan, opaque

(Garrison-Schilling, Grau et al. 2011)

(Chen, Wu et al. 2003)

Newly isolated strains
132a11

environmental isolate, opaque

M. E. Janes

132z21

environmental isolate, opaque

M. E. Janes

212b61

environmental isolate, opaque

M. E. Janes

212f151

environmental isolate, opaque

M. E. Janes

212f181

environmental isolate, opaque

M. E. Janes

212s71

environmental isolate, opaque

M. E. Janes

324e91

environmental isolate, opaque

M. E. Janes

342s61

environmental isolate, opaque

M. E. Janes

NOLA181

environmental isolate, New Orleans, LA, opaque

Lab collection

1

strains used for brp distribution analysis

2

strains used for wzb distribution analysis
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Switching assays: Phase switching assays in HI were performed as previously described
(Garrison-Schilling, Grau et al. 2011). Single isolated colonies were inoculated and grown ON in
HI broth for 16-24 hours with shaking at 200 rpm, 30°C. ON’s were then subcultured 1:100 into 3
ml of fresh HI broth daily for a total of 15 days and grown as mentioned above. Each subculture
was termed a passage. Occurrence of phase variation was assayed by plating serial dilutions of
each culture onto HI agar after ON and every fifth passage. Phenotypes were scored as opaque
(O)- capsule producing colonies, translucent (T)- colonies with no capsule production, rugose (R)dry wrinkled colonies, sectored (S)- two phenotypes in one colony, others(Ot)- colonies which
exhibit intermediate capsule production and any other phenotype not categorized above. Percent
switching frequencies were calculated by using the formula: 100 * (number of colonies of a
particular phenotype divided by the total number of colonies counted for that particular passage).
Molecular genetic and recombinant DNA techniques: DNA manipulations were carried
out using standard molecular techniques (Sambrook, Fritsch et al. 1989). Restriction enzymes,
were obtained from New England Biolabs, Pfu polymerase from Stratagene, AmpliTaq
polymerase from Applied Biosystems, and primers (Table 4.4) from Sigma Genosys. Genomic
DNA was isolated and PCRs for brp gene linkage analysis and for the wzb gene were completed
all as described (Grau, Henk et al. 2008, Garrison-Schilling, Grau et al. 2011). Briefly, 100 ng of
gDNA was amplified in a 25 µl reaction consisting of 2.5 µl 10X PCR buffer, 10% DMSO, 2 µl
10 mM total DNTP’s, 1.5 µl 25 mM MgCl2, 1.25 µl each of 20 µM primers and 0.2 µl of 5U/ µl
Amplitaq. PCR reactions were performed as follows: initial denaturation for 94°C -1 min, followed
by 35 cycles of 94°C -1 min, 55 °C -1 min, 72 °C -2 min, and a final extension of 72°C -5 min and
hold at 4 °C. For Southern blotting, fragments specific for the brpC, brpF, brpH, and brpK genes
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were generated via PCR with primer pairs RUG17/RUG18, RUG33/RUG34, CAP25/CAP26, and
RUG43/RUG44, respectively. Production of radiolabeled probes and hybridizations were
performed as described (Grau, Henk et al. 2008) using ca. 108 cpm/ml of probe per hybridization.

Table 4.4: Primers used in this study
Primer

Sequence (5′3′)

Description

RUG131

CGAGAGAGATGAGAGCAATG

Used to demonstrate brpA-brpB linkage

RUG161

TTCCTCTCGCAATACGCCAC

RUG151

CAAGAGCATACGACCTGGAC

RUG181

TGGCGAGGATGACTTATCAA

RUG191

ACGCAGACCTCCACTAGAGA

RUG341

GAAGGTGCAGGAAGAGTTGA

CAP251

GTAGAGTGGCAGATCGTACA

CAP281

TGTCACGCAACTGCTGTTCT

CAP271

TACCAATCTAACGCCGGCAA

RUG451

AATCCAATGAGCAGCGAAGTCC

Used to demonstrate brpB-brpC linkage

Used to demonstrate brpD-brpF linkage

Used to demonstrate brpH-brpI linkage

Used to demonstrate brpI-brpJ linkage
(CAP27 also used with CAP28 to
generate brpI probe

RUG43

AGCCAGAAGATAGCCTGTC

Used to demonstrate brpJ-brpK linkage

RUG461

AGCGATACGCCATGTTACTCC
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(Table 4.4 continued)
Primer

Sequence (5′3′)

RUG44

GGAGTCGAGCTCTTCATTCC

RUG173

CGGAACTTATTAATCGAGAC

wza-For2

GGTGCTCTACGCGTTAAAACG

wzc-Rev2

GAGTTATCAACGGAAGATCGG

Description
Used to generate brpK probe (with RUG43)
Used with RUG18 to generate brpC probe

Used to amplify wzb gene

1

From Grau, et al. 2008 (Grau, Henk et al. 2008).

2

From Garrison-Schilling, et al. 2011 (Garrison-Schilling, Grau et al. 2011).

3

From B. Grau dissertation, LSU, May 2006.
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CHAPTER 5
CONCLUDING REMARKS AND FUTURE DIRECTIONS
Phase variation in the human pathogen, V. vulnificus, involves the conversion among the
capsule producing opaque virulent, unencapsulated translucent avirulent, and the biofilm
proficient rugose phenotypes (Grau, Henk et al. 2005). Though a few studies in the past have
attempted to identify the environmental triggers (Hilton, Rosche et al. 2006, Garrison-Schilling,
Grau et al. 2011) and genetic mechanisms causing phase variation (Chatzidaki-Livanis, Jones et
al. 2006, Grau, Henk et al. 2008) in V. vulnificus, many questions still remain unanswered. Our
goal in this study was to identify additional environmental factors and genes that lie at the basis of
phase switching in V. vulnificus. Here, we also focused on elucidating the proteomic differences
between the virulent opaque and biofilm proficient rugose phenotypes.
Our study demonstrated that of all the divalent cations tested besides calcium, manganese
at millimolar levels can induce opaque virulent strains to switch to either the less-virulent
translucent or biofilm-efficient rugose forms (Figure 2.1, 2.3 – 2.8, 2.10). Our attempt in this study
was also to identify the genetic components of manganese-induced phase variation in V. vulnificus.
Our data showed that one of the mechanisms by which translucent colonies arise from opaque
colonies while subjected to manganese is through deletions in the wzb gene (a tyrosine phosphatase
involved in capsular polysaccharide chain elongation), caused by homologous recombination
between the direct flanking repeats adjacent to wzb (Chatzidaki-Livanis, Jones et al. 2006). It
would be interesting to study how increased Ca2+ and Mn2+ in the growth media could regulate
genetic recombination events leading to deletion of the wzb gene. However, not all the translucent
colonies showed this deletion. In fact, the majority of the translucent colonies tested had an intact
wzb gene. Reduced transcription (Rosche, Smith et al. 2006) or transcriptional inhibition of the
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wzb gene would also explain the presence of these translucent colonies with the intact wzb gene.
Testing if the presence of Ca2+ and Mn2+ could affect transcription of the wzb gene, and elucidation
of the molecular mechanism involved will also help us better understand the process of Ca2+ and
Mn2+ induced phase variation in V.vulnificus. Additionally, one of the translucent colonies seemed
to have an insertion or a duplication event as a longer than predicted band was visible upon PCR
amplification. It would be interesting to determine the genetic sequence of the wzb locus in this
strain in order to examine the possible link of this insertion or duplication event to the translucent
phenotype of the strain.
Previous studies in our lab showed that an rpoS mutant was unable to phase vary in the
presence of Ca2+ (Garrison-Schilling dissertation, LSU, 2011). In our study here, we also saw that
the rpoS mutant displayed reduced phase variation in the presence of Mn2+ compared to the wild
type strain. These results indicate that Ca2+ and Mn2+ induced phase variation in V.vulnificus
appears to involve rpoS. In Pseudoalteromonas sp., RpoS has been shown to suppress the
expression of mutS (a DNA mismatch repair protein), and therefore increase the frequency of gac
(two component signal transduction components) mutants, leading to increased phase variation
(van den Broek, 2005). It would be interesting to study the molecular mechanism of how rpoS is
involved in Ca2+ and Mn2+ induced phase variation. Also, the complemented construct created in
this study did not increase the ability of the mutant to phase vary. This could be because
overexpression of rpoS, which is a stationary phase stress response regulator in bacteria, might
affect its functioning in ways unknown. It would only be logical to express rpoS under its
endogenous promoter and assess if phase variation is restored in the complemented strain in the
presence of manganese.
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Previous experiments from our lab demonstrated that calcium could enhance phase
variation and biofilm formation of V. vulnificus (Garrison-Schilling, 2011). However,
supplementation of calcium to Vibrio parahaemolyticus did not have the same effect (see
Appendix A, Figure A1-A3). Here we found that supplementation of the medium with manganese
also promoted biofilm formation of V. vulnificus. Of the 3 EPS-related clusters in V. vulnificus,
the brp and rbd clusters have been shown to have functions in biofilm formation (Grau, Henk et
al. 2008, Guo and Rowe-Magnus 2010, Guo, 2011, Kim, Park et al. 2009); thus, it would be
interesting to study whether changes in expression of these genes lie at the basis of manganeseand calcium-mediated upregulation of biofilms. In B. subtilis, the simultaneous presence of
glycerol and manganese has been shown to stimulate biofilm formation. A role for Mn2+ as a
cofactor has been proposed in this process, wherein it could either act as a cofactor in the binding
of glycerol to the sensor KinD domain or, it could act as a cofactor for SpoOF, a sporulation factor,
enhancing the downstream signal phosphorelay (Shemesh and Chai 2013). One cannot deny the
possibility of Mn2+ acting as cofactor for proteins involved in the process of biofilm formation in
V.vulnificus. Additionally, changes in levels of Mn2+ in the growth medium have been shown to
alter the activity of a Mn2+ binding regulator, PsaR, which further affects gene expression by
altering the levels of RNA transcripts of several genes in S. pneumoniae (Johnston, Briles et al.
2006). There is also a possibility that Mn2+ may regulate expression of genes involved in biofilm
formation in V.vulnificus as previously seen in S. mutans, where, SloR, which is a Fe3+- Mn2+
transcriptional metalloregulator, influences genes affecting sucrose dependent and sucrose
independent biofilms (Rolerson, 2006).
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Here, we also attempted to study the dual effect of temperature and media composition on
V. vulnificus phase variation. Our data showed that both translucent and rugose colonies were
observed at 30°C in LB2, LB2+Ca and LB2+Mn. Though LB2 and LB2+Mn showed propensity
to switch to translucent colonies at 37°C, no such relationship was seen in LB2+Ca (see Appendix
B, Figure B1- B3) and further studies need to be performed to decipher the different results
observed.
The results from the two dimensional gel electrophoresis (2DGE) and mass spectrometry
(MS) experiments identified several proteins whose expression either increased, decreased or was
solely observed in the rugose phenotype (Table 3.1). One of the proteins identified by mass MS
and Swiss Prot analysis to be increased in the rugose phenotype was MalE (maltose binding
periplasmic protein). Since phase variation in V. vulnificus is characterized by changes in surface
polysaccharide expression, we chose to study the role of malE (VVA0397) in the rugose phenotype
and biofilm formation in V. vulnificus. The increased expression of MalE protein (Table 3.1) along
with the transcriptional upregulation of malE (Figure 3.2) in the rugose phenotype was very
interesting as it has been previously shown that maltose inhibits biofilm formation in V. cholerae
(Ali, Morris et al. 2005). Also, it has been demonstrated in V. vulnificus that the presence of
maltose in the medium does not induce biofilm formation (Kim, Park et al. 2009). The seemingly
contradictory nature of our 2DGE, RNA dot blot results and the published literature led us to
construct a malE mutant, which would help to dissect the role of malE in V. vulnificus biofilm
formation and the rugose phenotype. Interestingly, the malE mutant generated retained the rugose
phenotype indicating that malE is not required for the rugosity phenotype of V. vulnificus under
the conditions used in this study. Nevertheless, the fact that both the MalE protein and the malE
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transcript was increased in the rugose phenotype suggests a role for the MalE in the same. Since,
we did not observe the expected non rugose phenotype in the malE (VVA0397) mutant, it is
possible that there exists another protein which compensates for the loss of malE function. In fact,
there exists the gene VVA0056 (protein Q7MGB3), which is also designated as coding for a
maltose binding periplasmic protein in the genome of YJ016 and is 56 % identical in amino acid
composition to the VVA0397 product. Construction of a double mutant would further address the
potential role of MalE and its paralogs in rugosity.
There is also the possibility that maltose or a maltodextrin, which are sugars transported
by the maltose transport system could act as a signal for rugose colony or biofilm formation. This
can be assessed by supplementation of these sugars to the medium to observe if an opaque colony
can develop rugosity. Alternatively, it is possible that maltose and/or a maltodextrin could form
an integral part of the exopolysaccharide (EPS) matrix. The composition and structure of the V.
vulnificus EPS can be determined by polysaccharide analysis of the rugose matrix by using a
combination of nuclear magnetic resonance (NMR), chromatography and mass spectrometry (MS)
(Yildiz, Fong et al. 2014). In addition to substrate translocation, MalE proteins can also play roles
in signal recognition in chemotaxis (Ehrmann, Ehrle et al. 1998) and as chaperones Richarme,
1997).
In addition to the MalE protein, our study identified a number of proteins like adenosine
deaminase, alanine racemase, pantothenate synthase, Clp proteases, and a hypothetical
uncharacterized protein (VVA0984 gene product), whose production was increased in the rugose
phenotype compared to the opaque and it would be interesting to study the role of these proteins
in rugosity and biofilm formation of V. vulnificus.
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Lastly, we showed that the brp locus, which functions in exopolysaccharide biosynthesis
and transport (Grau, Henk et al. 2008, Guo and Rowe-Magnus 2010), is very well conserved in
both the previously existing strains in the laboratory as well as the newly isolated V. vulnificus
strains from the environment. Though the PCR results showed that all the wcr genes were present
in all but one of the 42 previously existing and new strains tested, some of the newly isolated
strains exhibited a different 2.7 kb restriction fragment length polymorphism (RFLP) in addition
to the expected 10.5 kb band. Despite the different 2.7 kb RFLP profile the ability of such strains
to form rugose colonies was retained indicating that mutations taking place at this locus could be
silent. Sequencing of the genetic loci of some of these strains harboring the alternate RFLP profile
will help us determine the nature of genetic changes occurring here.
Overall, the findings presented in this study not only resulted in a better understanding of
the processes of phase variation and rugose colony formation in V. vulnificus, but they also are a
step forward towards potential applications to better control human diseases caused by V.
vulnificus.
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APPENDIX A
EFFECT OF CALCIUM ON V. PARAHAEMOLYTICUS PHASE VARIATION
Vibrio parahaemolyticus is a close relative of Vibrio vulnificus and is a leading cause of
gastroenteritis in the United States. As observed in V. vulnificus, the opaque and translucent
phenotypes have also been reported in V. parahaemolyticus and exhibit phase variation from one
phenotype to the other (McCarter 1998, McCarter 1999).
Since previous studies in our lab indicated that V. parahaemolyticus strain ATCC17802
does not undergo phase variation in the presence of calcium, we wanted to test if this is simply a
strain-specific phenomenon or whether calcium does not generally affect phase variation in V.
parahaemolyticus. We therefore performed switching assays on V. parahaemolyticus strains
ATCC17802, ATCC33847 and ATCC49529 in LB2 and LB2 supplemented with 1 mM calcium.
Switching assays were carried out as previously described (Garrison-Schilling, 2011).
Strain ATCC17802, as previously observed in the presence of LB2+Ca, did not show any
significant translucent or rugose colonies at all passages tested. In fact switching to 14.9 ± 14.0 %
and 54.9 ± 34.4 % translucent phenotype was seen after 10 and 15 passages in LB2 (Figure A1).
Strain ATCC33847 showed switching to predominantly 6.6 ± 7.9 %, 18.8 ± 17.1 % and
19.4 ± 11.3 % rugose colonies after 5, 10, 15 passages in LB2. Also little switching to 5.7 ± 13.7
% translucent colonies was observed after the 15th passage in LB2. However, in the presence of
calcium 16.2 ± 16.1 % rugose colonies were seen after 15 passages but no switching was observed
earlier (Figure A2).
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Figure A1: Response of V.parahaemolyticus strain ATCC17802 to increased calcium. Switching
assays were carried out in LB2 and LB2+Ca. Phase variation was assessed at passages 5,10,15 by
plating on LB2 agar. The proportion of different phenotypes was calculated for 6 independent
experments and means and standard deviations are presented here.
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Figure A2: Response of V.parahaemolyticus strain ATCC33847 to increased calcium. Switching
assays were carried out in LB2 and LB2+Ca. Phase variation was assessed at passages 5,10,15 by
plating on LB2 agar. The proportion of different phenotypes was calculated for 6 independent
experments and means and standard deviations are presented here.
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Strain ATCC49529 showed very little switching to 2.5 ± 6.0 % , 1.8 ± 2.2 % , 6.1 ± 5.7 %
translucent colonies after 5, 10, 15 passages respectively and 2.5 ± 6.1 % , 1.4 ± 1.2 % rugose
colonies after passage 10 and 15 in LB2. However, in the presence of calcium, scant switching to
0.1 ± 0.3 %, 0.3 ± 0.8 % translucent and 0.3 ± 0.6 % , 0.2 ± 0.5 % rugose colonies was observed
after passage 10 and 15, respectively (Figure A3).
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Figure A3: Response of V.parahaemolyticus strain ATCC49529 to increased calcium. Switching
assays were carried out in LB2 and LB2+Ca. Phase variation was assessed at passages 5,10,15 by
plating on LB2 agar. The proportion of different phenotypes was calculated for 6 independent
experments and means and standard deviations are presented here.

These results from the switching assays indicated that calcium seems to reduce phase
variation in V.parahaemolyticus and different strains exhibit different patterns of switching to
either the translucent or the rugose phenotypes.

109

APPENDIX B
SIMULTANEOUS EFFECT OF CHANGING TEMPERATURE AND ADDITION OF
DIFFERENT DIVALENT CATIONS ON V. VULNIFICUS PHASE VARIATION
Temperature has been shown to influence phase variation in V. vulnificus (Hilton, 2006).
Also, previous studies in our lab demonstrated that of all the temperatures tested i.e. 15°C, 20°C,
25°C, 30°C and 37°C, maximum phase variation of strain 1003(O) occurred to 72.0 ± 38.7 %
translucent colonies at passage 15 in HI medium at 30 °C (J. Finley and G.S. Pettis, unpublished
results). Switching frequencies at other temperatures were lower than that seen at 30°C. At 37°C
and 25°C switching occurred to the translucent form at a frequency of 2.5 ± 3.8 % and 2.2 ± 1.0
% respectively. At 20°C, 0.2 ± 0.2 % translucent colonies were observed, whereas no switching
was observed at 15°C. This data indicated that phase variation in V. vulnificus occurs in a specific
temperature range. Previous data regarding calcium supplementation (Garrison-Schilling, 2011)
and our current data regarding manganese have indicated that addition of these to the media results
in CPS or EPS phase variation in V. vulnificus. We therefore wanted to study if changes in
temperature and cation simultaneously affect phase variation. Switching assays were performed
on strain 1003(O) in the presence of LB, LB2+Ca or LB2+Mn each at 30°C and 37°C.
Switching assays in LB2 at 30°C seems to bring about phase variation to both 34.9 ± 50.0
% translucent and 25.3 ± 43.3 % rugose colonies after 15 passages. However, switching assays at
37°C in LB2 brings about phase variation to predominantly 14.4 ± 17.1 %, 70.5 ± 44.0 %, 97.0 ±
3.7 % translucent colonies after passages 5,10, and 15 respectively (Figure B1).
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Figure B1: Effect of changing temperature on V. vulnificus strain 1003(O) in LB2 medium.
Switching assays were perormed as mentioned above and colonies counted after ON, 5, 10, 15
passages. Data presented here are averages and standard deviations of 3 independent experiments.

In the presence of calcium at 30°C, phase variation to both translucent (max 50.6 ± 12.8 %
at passage 10) and rugose (max 44.8 ± 33.1 % at passage 5) colonies was seen at all passages. At
37°C, rugose colonies were seen at all passages (max 50.9 ± 41.6 % at passage 5). Even though
37.9 ± 28.9 % translucent colonies were observed at passage 5, their numbers dwindled with each
successive passage (12.0 ± 18.8 %, 0.3 ± 0.2 % at passages 5, 10 respectively) (Figure B2).
In the presence of manganese at 30°C, phase variation was seen to mostly 97.2 ± 1.0 %,
44.0 ± 49.8 %, 98.3 ± 1.3 % translucent colonies at 5, 10, 15 passages respectively. 52.4 ± 49.5
% rugose colonies were also seen at passage 10. However at 37°C exclusively 88.4 ± 13.8 %, 79.6
± 33.7 %, 99.7 ± 0.0 % translucent colonies were observed at all passages (Figure B3).
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Figure B2: Effect of changing temperature on V. vulnificus strain 1003(O) in LB2+Ca medium.
Switching assays were performed as mentioned above and colonies counted after ON, 5, 10, 15
passages. Data presented here are averages and standard deviations of 3 independent experiments.
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Figure B3: Effect of changing temperature on V. vulnificus strain 1003(O) in LB2+Mn medium.
Switching assays were performed as mentioned above and colonies counted after ON, 5, 10, 15
passages. Data presented here are averages and standard deviations of 3 independent experiments.
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Our preliminary data from LB2 and LB2+ Mn at 37 °C shows that there is a propensity for
strain 1003(O) to switch from opaque to the translucent phenotypes. In the presence of LB2+Ca at
37°C, though both translucent and rugose colonies are seen at passages 5 & 10, the number of
translucent colonies decrease successively. However, at 30°C, both rugose and translucent
colonies were seen in all media though at different time points during the switching assays (passage
15 in LB2, all passages in LB2+Ca and passage 10 in LB2+Mn). Further work needs to be
undertaken to discern these differences observed due to the dual effects of temperature and media
composition on phase variation.
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APPENDIX C
SUPPLEMENTARY DATA FOR CHAPTER 3
Table C1: Mass spectrometry results of proteins identified to be differentially expressed between the rugose and opaque V.vulnificus
phase variants using Peaks, PLGS or MASCOT software.
PDQuest

Hits

Organism

Spot #

Accession

MW

number

(Da)

-

-

1502

No hits

-

1503

Polar

V. parahaemolyticus Q56702

39,824

pI

Coverage MASCOT
%

4.67

Peptide sequence

score

-

-

-

14.36

-

AAGLQISNRb
(R)IAETTSFGGNK(L)a,b

flagellin A

(K)DDAAGLQISNR(L) a,b
AINVNTNVSAM[2]TAQRb
(K)SQILQQASTSILAQAK(Q) a
(R)VAIQEEVTALNDQLNR(I) a
Phospho- V.vulnificus

Q8DCA0

40,811 4.63

- glycerate
kinase

114

5.18

-

(K)LTVLESLSK(I) a,b

-

(K)AFDENAEAEIK(H) a,b

-

SLYEADLVETAQKb

(Table C1 continued)
PDQuest Hits

Organism

Spot #

Accession MW
number

pI

Coverage MASCOT

(Da)

%

Peptide sequence

score
PAVEM[2]LEARb

1601

No hits

-

1602

Polar

V.

flagellin C

parahaemolyticus

2510

Adenosine

-

Q56712

V.vulnificus Q8D6Q8

-

40,787

36,959

-

4.38

-

15.11

4.72

32.33

deaminase

115

-

-

-

(R)IAETTSFGGR(R) a,b

-

(K)DDAAGLQISNR(L) a,b

-

(R)LSHSINNLANVQENVDASNSR(I) a

-

AVTVSTNVSAM[2]TAQRb

-

(K)AQILQQAGTSILAQAK(Q) a,b

-

(R)FGPLLHQVK(G) a,b

-

(-)MNYFDLPK(I) a,b

-

(K)DGIAVTINTDNR(T) a,b

-

(R)AEAQYDIHGNYILSILR(T) a,b

-

(K)GLSLDDIMDSVVR(G) a,b

(Table C1 continued)
PDQuest

Hits

Organism

Spot #

2601

Accession MW
number

Polar

V.

Q56702

flagellin

parahaemolyticus

pI

Coverage MASCOT

(Da)

40,148 4.70

%

43.39

B/D

116

Peptide sequence

score
-

(R)ISFELFEDAANENVK(Y) a,b

-

(K)GEEVALETCPSSNVQTK(A) a,b

-

(R)FELPGMMMQTAEALER(I) a,b

-

PQTIIDLADEQNLTLPSR b

-

AGEQGAGQNVYDAISLLGAER b

-

(K)LQIFAGNNK(V) a,b

-

(R)AELGAFQNR(F) a,b

-

(K)SQILSQASSSILAQAK(Q) a

-

(R)IAETTSFGGNK(L) a,b

-

(K)DDAAGLQISNR(L) a,b

-

(R)VAIQEEVTALNDELNR(I) a,b

-

(R)DLSLQSANGSNSK(A) a,b

(Table C1 continued)
PDQuest

Hits

Organism

Spot #

Accession MW
number

pI

Coverage

(Da)

%

MASCOT

Peptide sequence

score
-

(R)FNHAISNLDNINENVNASK(S) a

-

(R)FNHAISNLDNINENVNASK(S) a,b

-

(-)AVNVNTNVSAMTAQR(Y) a,b

-

(-)AVNVNTNVSAMTAQR(Y) a,b

-

(K)SQILSQASSSILAQAK(Q) a

-

AISNLDNINENVNASKb

-

(R)YLNNANSAQQTSMER(L) a,b

- (R)NANDGISIAQTAEGAMNETTNILQR(M)a,b

Phosphoglycerate

V.

Q8DCA0

40,718

4.55

vulnificus

117

28.24

-

(R)VAIQEEVTALNDELNR(I) a,b

-

(R)FNHAISNLDNINENVNASK(S) a,b

-

(K)AGDDIEELATYINGQTDLVK(A) a,b

-

(R)IIASLPTIK(L)a,b

-

(K)LTVLESLSK(I)a,b

(Table C1 continued)
PDQuest

Hits

Organism

Spot #

Accession MW
number

pI

Coverage MASCOT

(Da)

%

kinase

Peptide sequence

score
-

PAVEM[2]LEARb

-

(K)AMSNPERPLVAIVGGSK(V) a,b

-

(K)AFDENAEAEIK(H) a,b

-

(K)VLPAVEMLEAR(A) a,b

-

AGPLLAAELEALGKb

-

(K)SLYEADLVETAQK(L)a,b

-

(K)SLYESDLVETAQK(L)a

-

(K)TILWNGPVGVFEFK(N) a,b

- (K)IADQLVVGGGIANTFIAAEGHNVGK(S) a,b
3504

Pantothenate V.vulnificus

Q7MHV3 33,587 4.83

7.31

Synthetase

118

-

(R)ADDLNNYPR(T) a,b

-

(R)LIDNQVVELVK(D) a,b

-

(-)MQTFAEISALR(E) a,b

-

(R)DDFASIIEDASDQLR(A) a,b

(Table C1 continued)
PDQuest

Hits

Organism

Spot #
4208

Accession MW
number

(Da)

P52626

27,481

pI

Coverage MASCOT
%

Peptide sequence

score
-

(K)TYDTGIEHDVALGR(A) a,b

acid ABC

-

(R)YFPFTFVK(Q) a,b

transporter

-

DTGIEHDVALGRb

binding protein

-

FSGLFGLLETGRb

-

(K)TYDTGIEHDVALGR(A)a

-

(R)IDTISNQITMTDAR(K) a,b

-

(K)TVAVNLGSNFEQLLR(D) a,b

-

(K)YLFADPYVVDGAQITVR(K) a,b

-

QKPYAATLLTSQKb

-

(K)LGATPFIER(V)a

flavoprotein

-

AEALEQEAKb

alpha-component

-

(K)LGATPFIER(V)a,b

-

(K)DVHQAFVAVAEQEGK(M) a,b

Putative amino V. harveyi

4805 Sulfite

V.vulnificus Q7MHA5|

reductase

67,239

5.25

27.42

4.93

CYSJ_VIBVY

119

27.44

(Table C1 continued)
PDQuest
Spot #

Hits

Organism

Accession MW
number

pI

Coverage

(Da)

%

120

MASCOT

Peptide sequence

score
-

(R)FGGASGYLAQR(L) a,b

-

(K)GVAEALEQEAK(A) a,b

-

PYAATLLTSQKb

-

(K)LTAEELVGLLR(R) a,b

-

(K)VFVENNNNFK(L) a,b

-

(K)LTAEELMGLLR(R) a

-

(R)GDAEEFINDLR(K) a,b

-

(K)LTIIFASQTGNAK(G) a,b

-

(K)QKPYAATLLTSQK(I) a

-

(K)QKPYAATLLTSQK(I) a,b

-

(K)LPADDNVPVIMVGPGTGIAPFR(S) a,b

-

(K)FEITSSNPQQVEK(F) a,b

-

(K)AEGIAVQLFDASDYK(G) a,b

-

(K)DVHQAFVAVAEQEGK(M) a,b

(Table C1 continued)
PDQuest Hits

Organism

Spot #

5403

Accession MW
number

pI

Coverage

(Da)

%

MASCOT

Peptide sequence

score
-

(R)EYAGNTQLVDLLAEK(Q) a,b

-

(R)EYSGNTQLVDLLAEK(Q) a

-

(K)LPADDNVPVIMVGPGTGIAPFR(S) a,b

V.vulnificus Q7MIG1 29,923

5.10

5.36

-

(K)IGVVVAGEGDAETLK(H) a,b

Glyceraldehyde Escherichia P0C8Z1 31,384

5.97

8.16

-

(K)KVVLTGPSK(D) a,b

Elongation
factor Ts

3 phosphate

fergusonii

dehydrogenase
A fragment
7602

No hits

-

7710

Alanine

V.

racemase 2

vulnificus

-

-

-

Q8D6Q0 44,078 5.72

6.13

-

(K)AQVLINGQR(A) a,b
(R)NGIDMSTER(G) a,b
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-

(R)ESGFEGELIR(V) a,b

-

(K)VHLALNDGGMGR(N) a,b

(Table C1 continued)
PDQuest

Hits

Organism

Spot #

1616

Accession MW
number

Putative

V.vulnificus

pI

Coverage

MASCOT

%

score

(Da)

Q8DD27 33,196

4.31

Peptide sequence

-

PGDEVTLFGAQKb

-

(K)GVLPGDEVTLFGAQK(N) a,b

3.63

-

(K)VGDEVAIVGIK(D) a,b

elongation factor
Tu like protein
1505 Maltose

E.aerogenes

43,109

9.07

6.82

48

GYNGLAEVGKa,b,c

Q7MH72 44,476

4.68

16.87

75

EELVADYIYPTLKa,b,c

98

ASGASECYVVDLKa,b,c

86

FEGAFAALAPDLKa,b,c

64

EQCLDYLAERa,b,c

P18815

binding periplasmic protein
2708

Argino-

V.vulnificus

-succinate synthase

122

11

NIPCAASLTKa,b,c

52

AVEQLVLDKa,b,c

(Table C1 continued)
PDQuest

Hits

Organism

Spot #

Accession MW
number

ATP synthase V.vulnificus

pI

Coverage

MASCOT

%

score

(Da)

Q7MG10 50,691

4.63

18.42

subunit beta

Trigger factor V.vulnificus

22

QLDPLVVGQEHYDTARa,b,c

62

GVEVVNTGAPISVPVGTKa,b,c

52

LVLEVQQQLGGGVVRa,b,c

62

YTLAGTEVSALLGRa,b,c

64

IMNVLGDAIDERa,b,c

55

VALTGLTMAERa
FGVAEGGIDALKa,b,c

4.61

2.78

57

-

-

-

18.5

32

R.LLAEHTGQPIEVIER.Da,b,c

dependent Clp

82

DNFMSADQAVEYGLVDAVLTHRa,b,c

proteolytic subunit

89

LLAEHTGQPIEVIERa,b,c

17

YVLPNSRa,b,c

3706

No hits

4206

ATP

V.vulnificus

Q7MMG8 48,280

Peptide sequence

Q7MMG7

-

21,986 5.00

123

-

(Table C1 continued)
PDQuest

Hits

Organism

Coverage

MASCOT

%

score

11.54

35

VLVLVAAPEGIEALEKa,b,c

phosphoribosyl-

25

GYIVPGLGDAGDKa,b,c

-transferase

48

ISVVGIYRa,b,c

Spot #

number
Uracil

4509

Accession MW

V.vulnificus

pI

(Da)

Q7MIK2 22,721 5.34

Peptide sequence

36,104

4.28

2.47

51

VGLYEPIRa,b,c

V.vulnificus Q8DD27 33,196

4.31

6.93

62

IVELAEALDSYIPEPERa,b,c

elongation factor

53

VGDEVAIVGIKa,b,c

Tu like protein

48

AGENVGALLRa,b,c

o Succinyl-

V.fischeri

B5FFK8

- benzoate synthase
6809

Putative

Ninein like

Homo sapiens Q9Y2I6 156,247

4.82

0.58

41

LQAIQEERa,b,c

Q7MFN1 27,387

5.54

26.91

37

VITHSPSQFLDFLELRa,b,c

87

LDLASELLDSVGIDSHRa,b,c

46

EAHTQALLNVIQGGRa,b,c

53

GPIDELASLRa,b,c

protein
7306

Putative

V.vulnificus

hydrolase

124

(Table C1 continued)
PDQuest

Hits

Organism

Spot #

7510

Accession MW
number

pI

Coverage

(Da)

%

score
FLEGVAILRa,b,c

82

MADAVNNFLGPQMASAVDATSVRa,b,c

52

IVGNNPTVGIISSGAMVERa,b,c

72

FEPGLTLDDLVRa,b,c

72

IKDVAQVAGVRa,b,c

47

GGTLLQTFLKa,b,c

75

SVLDFDNGLNQLVVRa,b,c

37

K.LSQSIAEQPIVEMEK.Ga,b,c

48

IGAIELDESLEPGEYRa,b,c

small subunit

63

SGEVTVNEQVQKa,b,c

pseudouridine

45

FLCDALGATRa,b,c

synthase A

32

LAEGVQLRa,b,c

36

MFAALGNKa,b,c

Flagellar P

V.vulnificus

Q7MMV0 37,896 7.32

20.66

UPF0319

V.vulnificus

Q7MMT3 28,260 5.57

6.12

protein VV0984
5309

Peptide sequence

75

ring protein

5205

MASCOT

Ribosomal

V.vulnificus

Q8D8X2

26,575 5.11

23.18

125

(Table C1 continued)
PDQuest

Hits

Organism

Coverage

MASCOT

%

score

4.20

60

GISEIVAAQKa,b,c

13.72

55

TDDSDEMTITMVKa,b,c

A biosynthesis

78

NVATQENIATLSRa,b,c

bifunctional protein

43

K.ILLGISGGIAAYK.Ca,b,c

CoaBC

42

GAEVQVVMTKa,b,c

46

SILITAGPTRa,b,c

37

AALSMEILKa,b,c

Spot #

Accession MW
number

pI

(Da)

Ribonuclease PH V. vulnificus Q7MPT3 25,549 5.07
5604

Coenzyme

V.vulnificus

Q7MPS9 42,980 5.15

Peptide sequence

5404

No hits

-

-

-

-

-

-

-

1108

No hits

-

-

-

-

-

-

-

6808

Ninein

Homo

like protein

sapiens

Transcription

A.

factor TCP9

thaliana

Q9Y216

156,247 4.82

0.58

41

O64647

37,607

3.37

40

9.90

126

LQAIQEERa,b,c

LEEVAGKDQTLRa,b,c

(Table C1 continued)
PDQuest

Hits

Organism

Spot #
7301

Accession MW
number

pI

Coverage

(Da)

Dethiobiotin V.vulnificus Q7MLU7 24,621 5.42

%
32.6

synthase

a

: analyzed by PLGS

b

: analyzed by Peaks

c

: analyzed by MASCOT

127

MASCOT

Peptide sequence

score
51

VNPGTEHYAEIIDMLEERa,b,c

63

QEDLPVVLVVGIKa,b,c

49

AFFIAGTDTDVGKa,b,c

60

LGEIPYIPSAKa,b,c

65

VEIDYAVLSRa,b,c

58

R.TIGYKPVAAGSDK.Ta,b,c
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